Biotech Showcase 2015 EBD Group Demy-Colton Image Map
Share:
Email this page Share this on LinkedIn Share this on Twitter

Biotech Showcase™ 2015 Presenting Companies

Preliminary list of 2015 presenting companies

Click on any row to see more company information

Abzena Group
Abzena Group
(AIM:ABZA)
Cambridge, United Kingdom
Abzena provides a suite of services and technologies that enable the development of better biopharmaceuticals. Its service operations provide a growing revenue stream, and it ...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Abzena Group

Abzena Group
City: Cambridge
Country: United Kingdom
Ownership: PUBLIC
Ticker: ABZA
Stock exchange: AIM
Schedule information will be posted soon
Abzena provides a suite of services and technologies that enable the development of better biopharmaceuticals. Its service operations provide a growing revenue stream, and it sees the potential for additional revenue through royalty bearing licenses for the application of its technology by partners.
Connect with Abzena Group on partnering360®

Biotech Showcase™ 2015
ACEA Biosciences
ACEA Biosciences
San Diego, California, United States
ACEA Biosciences is a development stage biotechnology company with an emphasis on oncology and inflammation. The company’s pipeline includes 4 pre-clinical and clini...


Share this:Email this pageShare this on LinkedInShare this on Twitter

ACEA Biosciences

ACEA Biosciences
City: San Diego
State: California
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
ACEA Biosciences is a development stage biotechnology company with an emphasis on oncology and inflammation. The company’s pipeline includes 4 pre-clinical and clinical stage assets.

Visit: http://www.aceabio.com
Connect with ACEA Biosciences on partnering360®

Biotech Showcase™ 2015
Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc.
(NYSE-M:ATNM)
New York, New York, United States
Actinium is developing targeted payload immunotherapeutics for the treatment of advanced cancers. Its targeted radiotheraphy is based on its delivery platform for the ...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Actinium Pharmaceuticals, Inc.

Actinium Pharmaceuticals, Inc.
City: New York
State: New York
Country: United States
Ownership: PUBLIC
Ticker: ATNM
Stock exchange: NYSE-M
Schedule information will be posted soon
Actinium is developing targeted payload immunotherapeutics for the treatment of advanced cancers. Its targeted radiotheraphy is based on its delivery platform for the therapeutic use of alpha-emitting actinium-225 and bismuth-213 and certain beta emitting radiopharamceuticals in conjunction with monoclonal antibodies.

Visit: http://www.actiniumpharma.com
Connect with Actinium Pharmaceuticals, Inc. on partnering360®

Biotech Showcase™ 2015
Adaptimmune
Adaptimmune
Abingdon, United Kingdom



Share this:Email this pageShare this on LinkedInShare this on Twitter

Adaptimmune

Adaptimmune
City: Abingdon
Country: United Kingdom
Ownership: PRIVATE
Schedule information will be posted soon
Biotech Showcase™ 2015
Admedus
Admedus
(ASX:AHZ)
Minneapolis, Minnesota, United States
Admedus invests in and develops next generation technologies. Its lead regenerative tissue product, CardioCel, is on the market in the US and Europe. The company has diversifi...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Admedus

Admedus
City: Minneapolis
State: Minnesota
Country: United States
Ownership: PUBLIC
Ticker: AHZ
Stock exchange: ASX
Schedule information will be posted soon
Admedus invests in and develops next generation technologies. Its lead regenerative tissue product, CardioCel, is on the market in the US and Europe. The company has diversified assets that range from those in R&D to marketed products.

Visit: http://www.admedus.com
Connect with Admedus on partnering360®

Biotech Showcase™ 2015
Advanced Inhalation Therapies
Advanced Inhalation Therapies
Rehovot, Israel
This Phase 2 biopharmaceutical company develops Nitric Oxide formulations to treat various respiratory diseases. It has completed a successful Phase 2a trial for RSV and Cysti...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Advanced Inhalation Therapies

Advanced Inhalation Therapies
City: Rehovot
Country: Israel
Ownership: PRIVATE
Schedule information will be posted soon
This Phase 2 biopharmaceutical company develops Nitric Oxide formulations to treat various respiratory diseases. It has completed a successful Phase 2a trial for RSV and Cystic Fibrosis and plans to complete Phase 2b this winter and initiate Phase 3 trials late in 2015.

Visit: http://www.ait-pharm.com
Connect with Advanced Inhalation Therapies on partnering360®

Biotech Showcase™ 2015
Aeterna Zentaris
Aeterna Zentaris
(NASDAQ:AEZS)
Québec, Quebec, Canada



Share this:Email this pageShare this on LinkedInShare this on Twitter

Aeterna Zentaris

Aeterna Zentaris
City: Québec
State: Quebec
Country: Canada
Ownership: PUBLIC
Ticker: AEZS
Stock exchange: NASDAQ
Schedule information will be posted soon
Biotech Showcase™ 2015
Aethlon Medical, Inc.
Aethlon Medical, Inc.
(OTC:AEMD)
San Diego, California, United States
Aethlon Medical is a clinical stage company with a first-in-class device that selectively targets the rapid elimination of circulating viruses including Ebola, Hep C and HIV. ...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Aethlon Medical, Inc.

Aethlon Medical, Inc.
City: San Diego
State: California
Country: United States
Ownership: PUBLIC
Ticker: AEMD
Stock exchange: OTC
Schedule information will be posted soon
Aethlon Medical is a clinical stage company with a first-in-class device that selectively targets the rapid elimination of circulating viruses including Ebola, Hep C and HIV. It also targets tumor-secretive exosomes that promote cancer progression.

Visit: http://www.aethlonmedical.com
Connect with Aethlon Medical, Inc. on partnering360®

Biotech Showcase™ 2015
AgeneBio, Inc.
AgeneBio, Inc.
Baltimore, Pennsylvania, United States
AgeneBio is a clinical stage pharmaceutical company with a Phase 3 ready product that may slow the progression or delay the onset of Alzheimer’s dementia. It also has a smal...


Share this:Email this pageShare this on LinkedInShare this on Twitter

AgeneBio, Inc.

AgeneBio, Inc.
City: Baltimore
State: Pennsylvania
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
AgeneBio is a clinical stage pharmaceutical company with a Phase 3 ready product that may slow the progression or delay the onset of Alzheimer’s dementia. It also has a small molecule program targeting unmet needs in CNS diseases including aMCI, autism and schizophrenia.

Visit: http://www.agenebio.com
Connect with AgeneBio, Inc. on partnering360®

Biotech Showcase™ 2015
Amarantus Bioscience Holdings, Inc.
Amarantus Bioscience Holdings, Inc.
(OTCQB:AMBS)
San Francisco, California, United States
Amarantus Bioscience is a clinical stage biotechnology company that discovers and develops treatments and diagnostics for neurodegenerative diseases. The company has a Phase 2...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Amarantus Bioscience Holdings, Inc.

Amarantus Bioscience Holdings, Inc.
City: San Francisco
State: California
Country: United States
Ownership: PUBLIC
Ticker: AMBS
Stock exchange: OTCQB
Schedule information will be posted soon
Amarantus Bioscience is a clinical stage biotechnology company that discovers and develops treatments and diagnostics for neurodegenerative diseases. The company has a Phase 2b ready asset for Parkinson’s levodopa induced dyskinesia and has an exclusive license to the Lymphocyte Proliferation test.

Visit: http://www.amarantus.com/
Connect with Amarantus Bioscience Holdings, Inc. on partnering360®

Biotech Showcase™ 2015
Anavex Life Sciences Corp.
Anavex Life Sciences Corp.
(OTC:AVXL)
New York, New York, United States
Anavex is a clinical-stage biopharmaceutical company focused on the discovery of drug candidates to treat Alzheimer’s disease, other CNS diseases and various types of cancer...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Anavex Life Sciences Corp.

Anavex Life Sciences Corp.
City: New York
State: New York
Country: United States
Ownership: PUBLIC
Ticker: AVXL
Stock exchange: OTC
Schedule information will be posted soon
Anavex is a clinical-stage biopharmaceutical company focused on the discovery of drug candidates to treat Alzheimer’s disease, other CNS diseases and various types of cancer. Its lead product for Alzheimer’s is now in Phase 2 clinical trial.

Visit: http://www.anavex.com
Connect with Anavex Life Sciences Corp. on partnering360®

Biotech Showcase™ 2015
ANERGIS SA
ANERGIS SA
Epalinges, Switzerland
Anergis is a clinical stage company developing proprietary allergy vaccines that would require only 2 months of treatment. The clinical efficacy and disease modifying potentia...


Share this:Email this pageShare this on LinkedInShare this on Twitter

ANERGIS SA

ANERGIS SA
City: Epalinges
Country: Switzerland
Ownership: PRIVATE
Schedule information will be posted soon
Anergis is a clinical stage company developing proprietary allergy vaccines that would require only 2 months of treatment. The clinical efficacy and disease modifying potential of its lead candidate has been confirmed over two natural birch pollen seasons in 240 patients.

Visit: http://www.anergis.ch
Connect with ANERGIS SA on partnering360®

Biotech Showcase™ 2015
Antisense Therapeutics Ltd
Antisense Therapeutics Ltd
(ASX:ANP)
Toorak, Victoria, Australia
Antisense Therapeutics is developing an advanced stage pipeline of second-generation antisense drugs. Its lead compounds are in Phase 2 clinical development with near-term mil...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Antisense Therapeutics Ltd

Antisense Therapeutics Ltd
City: Toorak
State: Victoria
Country: Australia
Ownership: PUBLIC
Ticker: ANP
Stock exchange: ASX
Schedule information will be posted soon
Antisense Therapeutics is developing an advanced stage pipeline of second-generation antisense drugs. Its lead compounds are in Phase 2 clinical development with near-term milestones acting on validated targets in acromegaly and multiple sclerosis. It has a partnership and worldwide licensing agreement with Isis Pharmaceuticals.
Connect with Antisense Therapeutics Ltd on partnering360®

Biotech Showcase™ 2015
Apogenix GmbH
Apogenix GmbH
Heidelberg, Germany
Agogenix develops protein therapeutics for the treatment of diseases such as cancer by targeting pathways involved in growth, migration and apoptosis of diseased cells. Its mo...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Apogenix GmbH

Apogenix GmbH
City: Heidelberg
Country: Germany
Ownership: PRIVATE
Schedule information will be posted soon
Agogenix develops protein therapeutics for the treatment of diseases such as cancer by targeting pathways involved in growth, migration and apoptosis of diseased cells. Its most advanced product has successfully a controlled completed Phase 2 proof-of-concept study for the treatment of brain tumors.

Visit: http://www.apogenix.com
Connect with Apogenix GmbH on partnering360®

Biotech Showcase™ 2015
Apricus Biosciences Inc
Apricus Biosciences Inc
(NASDAQ:APRI)
San Diego, California, United States
This company’s lead product is approved for the treatment of erectile dysfunction in Europe and Canada and will be commercialized by its marketing partners. Its second-gener...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Apricus Biosciences Inc

Apricus Biosciences Inc
City: San Diego
State: California
Country: United States
Ownership: PUBLIC
Ticker: APRI
Stock exchange: NASDAQ
Schedule information will be posted soon
This company’s lead product is approved for the treatment of erectile dysfunction in Europe and Canada and will be commercialized by its marketing partners. Its second-generation of the device is under development. It has also recent initiated a Phase 2a trial for a product for the treatment of Raynaud’s phenomenon.

Visit: http://www.apricusbio.com
Connect with Apricus Biosciences Inc on partnering360®

Biotech Showcase™ 2015
Aptose Biosciences Inc.
Aptose Biosciences Inc.
(NASDAQ:APTO)
Toronto, Ontario, Canada
This clinical stage biotechnology company has a lead program that has completed a Phase 1 study in patients with solid tumors. It recently received IND allowance from the FDA ...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Aptose Biosciences Inc.

Aptose Biosciences Inc.
City: Toronto
State: Ontario
Country: Canada
Ownership: PUBLIC
Ticker: APTO
Stock exchange: NASDAQ
Schedule information will be posted soon
This clinical stage biotechnology company has a lead program that has completed a Phase 1 study in patients with solid tumors. It recently received IND allowance from the FDA to initiate a Phase 1b study in patients with relapsed/ refractory blood cancers including AML, high-risk MDA, lymphomas and multiple myeloma.

Visit: http://www.aptose.com
Connect with Aptose Biosciences Inc. on partnering360®

Biotech Showcase™ 2015
Aradigm Corporation
Aradigm Corporation
(NASDAQ:ARDM)
Hayward, California, United States



Share this:Email this pageShare this on LinkedInShare this on Twitter

Aradigm Corporation

Aradigm Corporation
City: Hayward
State: California
Country: United States
Ownership: PUBLIC
Ticker: ARDM
Stock exchange: NASDAQ
Schedule information will be posted soon
Biotech Showcase™ 2015
Arch Therapeutics (ARTH)
Arch Therapeutics (ARTH)
(OTCBB:ARTH)
Wellesley, Massachusetts, United States
Arch Therapeutics is a pre-clinical medical device company with an innovative approach to the rapid cessation of bleeding and control of fluid leakage during surgery and traum...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Arch Therapeutics (ARTH)

Arch Therapeutics (ARTH)
City: Wellesley
State: Massachusetts
Country: United States
Ownership: PUBLIC
Ticker: ARTH
Stock exchange: OTCBB
Schedule information will be posted soon
Arch Therapeutics is a pre-clinical medical device company with an innovative approach to the rapid cessation of bleeding and control of fluid leakage during surgery and trauma care. The underlying technology supports a platform of smart materials that address a specialized field that it calls ‘statis and barrier applications.’

Visit: http://www.archtherapeutics.com
Connect with Arch Therapeutics (ARTH) on partnering360®

Biotech Showcase™ 2015
Arcturus Therapeutics
Arcturus Therapeutics
San Diego, California, United States
Arcturus is a pre-clinical company targeting rare diseases.


Share this:Email this pageShare this on LinkedInShare this on Twitter

Arcturus Therapeutics

Arcturus Therapeutics
City: San Diego
State: California
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Biotech Showcase™ 2015
ARGEN-X NV
ARGEN-X NV
(EURONEXT:ARGX)
AH BREDA, Netherlands
arGEN-X is a clinical-stage biopharmaceutical company that creates and develops differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune disease...


Share this:Email this pageShare this on LinkedInShare this on Twitter

ARGEN-X NV

ARGEN-X NV
City: AH BREDA
Country: Netherlands
Ownership: PUBLIC
Ticker: ARGX
Stock exchange: EURONEXT
Schedule information will be posted soon
arGEN-X is a clinical-stage biopharmaceutical company that creates and develops differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases. It has generated a pipeline of differentiated antibody candidates through its discovery platform.

Visit: http://www.argen-x.com
Connect with ARGEN-X NV on partnering360®

Biotech Showcase™ 2015
Argos Therapeutics
Argos Therapeutics
(NASDAQ:ARGS)
Durham, North Carolina, United States
Argos Therapeutics is a biopharmaceutical company that develops and commercializes fully personal immunotherapies for the treatment of cancer and infectious disease. Its most ...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Argos Therapeutics

Argos Therapeutics
City: Durham
State: North Carolina
Country: United States
Ownership: PUBLIC
Ticker: ARGS
Stock exchange: NASDAQ
Schedule information will be posted soon
Argos Therapeutics is a biopharmaceutical company that develops and commercializes fully personal immunotherapies for the treatment of cancer and infectious disease. Its most advanced candidate is being evaluated in a pivotal Phase 3 trial for the treatment of metastatic renal cell carcinoma.

Visit: http://www.argostherapeutics.com
Connect with Argos Therapeutics on partnering360®

Biotech Showcase™ 2015
Aridis Pharmaceuticals, Inc.
Aridis Pharmaceuticals, Inc.
San Jose, California, United States
Aridis is a clinical stage biotech focusing on lung infections. Its portfolio includes anti-infective candidates and a human mAb platform. It has 2 mAbs in Phase 2a clinical t...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Aridis Pharmaceuticals, Inc.

Aridis Pharmaceuticals, Inc.
City: San Jose
State: California
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Aridis is a clinical stage biotech focusing on lung infections. Its portfolio includes anti-infective candidates and a human mAb platform. It has 2 mAbs in Phase 2a clinical testing in acute pneumonia and two anti-infective candidates at IND.

Visit: http://www.aridispharma.com
Connect with Aridis Pharmaceuticals, Inc. on partnering360®

Biotech Showcase™ 2015
Asceneuron SA
Asceneuron SA
Lausanne, Switzerland
Asceneuron is an early-stage biopharmaceutical company developing therapeutics for orphan tauopathies and improved symptomatic drugs for Alzheimer’s disease. Its lead small ...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Asceneuron SA

Asceneuron SA
City: Lausanne
Country: Switzerland
Ownership: PRIVATE
Schedule information will be posted soon
Asceneuron is an early-stage biopharmaceutical company developing therapeutics for orphan tauopathies and improved symptomatic drugs for Alzheimer’s disease. Its lead small molecule tau program is expected to enter Phase 1 development in 2015.

Visit: http://www.asceneuron.com
Connect with Asceneuron SA on partnering360®

Biotech Showcase™ 2015
Asterias Biotherapeutics
Asterias Biotherapeutics
(NYSE:AST)
Menlo Park, California, United States
Asterias Biotherapeutics develops products based on its core technology platforms of pluripotent stem sells and allogeneic dendritic cell immunotherapies. It has two clinical ...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Asterias Biotherapeutics

Asterias Biotherapeutics
City: Menlo Park
State: California
Country: United States
Ownership: PUBLIC
Ticker: AST
Stock exchange: NYSE
Schedule information will be posted soon
Asterias Biotherapeutics develops products based on its core technology platforms of pluripotent stem sells and allogeneic dendritic cell immunotherapies. It has two clinical stage programs, one AST-OPC1 for spinal cord injuries and one AST-VAC2 for lung cancer.

Visit: http://www.asteriasbiotherapeutics.com/
Connect with Asterias Biotherapeutics on partnering360®

Biotech Showcase™ 2015
Athersys, Inc.
Athersys, Inc.
(NASDAQ:ATHX)
Cleveland, Ohio, United States
Athersys is a clinical stage cell therapy company targeting neurological conditions, cardiovascular disease, inflammatory and immune disorders as well as other conditions. It...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Athersys, Inc.

Athersys, Inc.
City: Cleveland
State: Ohio
Country: United States
Ownership: PUBLIC
Ticker: ATHX
Stock exchange: NASDAQ
Schedule information will be posted soon
Athersys is a clinical stage cell therapy company targeting neurological conditions, cardiovascular disease, inflammatory and immune disorders as well as other conditions. It’s lead programs include a Phase 2 study in ischemic stroke and a Phase 2 study in acute myocardial infarction.

Visit: http://www.Athersys.com
Connect with Athersys, Inc. on partnering360®

Biotech Showcase™ 2015
Atossa Genetics, Inc.
Atossa Genetics, Inc.
(NASDAQ:ATOS)
Seattle, Washington, United States
Atossa Genetics is a commercial stage company targeting breast health through the development of laboratory services, medical devices and therapeutics.


Share this:Email this pageShare this on LinkedInShare this on Twitter

Atossa Genetics, Inc.

Atossa Genetics, Inc.
City: Seattle
State: Washington
Country: United States
Ownership: PUBLIC
Ticker: ATOS
Stock exchange: NASDAQ
Schedule information will be posted soon
Atossa Genetics is a commercial stage company targeting breast health through the development of laboratory services, medical devices and therapeutics.
Connect with Atossa Genetics, Inc. on partnering360®

Biotech Showcase™ 2015
Attana AB
Attana AB
Stockholm, Sweden
Attana AB is a commercial stage company that develops and markets biosensors to predict drug efficacy for pharmaceutical and diagnostic markets and for use by academic societi...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Attana AB

Attana AB
City: Stockholm
Country: Sweden
Ownership: PRIVATE
Schedule information will be posted soon
Attana AB is a commercial stage company that develops and markets biosensors to predict drug efficacy for pharmaceutical and diagnostic markets and for use by academic societies.

Visit: http://www.attana.com
Connect with Attana AB on partnering360®

Biotech Showcase™ 2015
AuraSense Therapeutics
Skokie, United States
This early stage biopharmaceutical company is developing a new class of nucleic acid it calls ‘spherical nucleic acid’ (SNA). SNAs provide a 3D presentation of oligonucleo...


Share this:Email this pageShare this on LinkedInShare this on Twitter

AuraSense Therapeutics

City: Skokie
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
This early stage biopharmaceutical company is developing a new class of nucleic acid it calls ‘spherical nucleic acid’ (SNA). SNAs provide a 3D presentation of oligonucleotides, which are able to enter cells and tissues without the use of transfection agents. It expects to file INDs in 2015.

Visit: http://www.aurasense.com
Connect with AuraSense Therapeutics on partnering360®

Biotech Showcase™ 2015
Avexxin AS
Avexxin AS
Trondheim, Norway
Avexxin is a clinical stage biopharmaceutical company developing and commercializing small molecule therapeutics for patients with chronic inflammatory conditions. It has a to...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Avexxin AS

Avexxin AS
City: Trondheim
Country: Norway
Ownership: PRIVATE
Schedule information will be posted soon
Avexxin is a clinical stage biopharmaceutical company developing and commercializing small molecule therapeutics for patients with chronic inflammatory conditions. It has a topical treatment for psoriasis in clinical development and pre-clinical assets for the treatment of rheumatoid arthritis.

Visit: http://www.avexxin.com
Connect with Avexxin AS on partnering360®

Biotech Showcase™ 2015
Aviara Pharmaceuticals
Aviara Pharmaceuticals
Houston, Texas, United States
Aviara develops small molecule pharmaceuticals to enhance the effectiveness of cell therapies and treat inflammatory diseases. Its lead clinical candidate is being developed f...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Aviara Pharmaceuticals

Aviara Pharmaceuticals
City: Houston
State: Texas
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Aviara develops small molecule pharmaceuticals to enhance the effectiveness of cell therapies and treat inflammatory diseases. Its lead clinical candidate is being developed for the mobilization of hematopoietic stem sells to the peripheral blood for autologous transplant in patients with leukemia or lymphoma.

Visit: http://www.aviarapharma.com
Connect with Aviara Pharmaceuticals on partnering360®

Biotech Showcase™ 2015
Axumbio
Murray, Utah, United States



Share this:Email this pageShare this on LinkedInShare this on Twitter

Axumbio

City: Murray
State: Utah
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Biotech Showcase™ 2015
Azevan Pharmaceuticals, Inc
Azevan Pharmaceuticals, Inc
Bethlehem, Pennsylvania, United States
Azevan’s first clinical compounds selectively block the effects of arginine vasopressin, a peptide neurochormone involved in the pathophysiology of stress-related CNS disord...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Azevan Pharmaceuticals, Inc

Azevan Pharmaceuticals, Inc
City: Bethlehem
State: Pennsylvania
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Azevan’s first clinical compounds selectively block the effects of arginine vasopressin, a peptide neurochormone involved in the pathophysiology of stress-related CNS disorders, including neuropsychiatric symptoms in neurodegenerative disease, intermittent explosive disorder, PTSD, and major depression. Its most advanced compound is in Phase 2 trial for intermittent explosive disorder.

Visit: http://www.azevan.com
Connect with Azevan Pharmaceuticals, Inc on partnering360®

Biotech Showcase™ 2015
BEAT BioTherapeutics
BEAT BioTherapeutics
Bellevue, Washington, United States
BEATBio is a preclinical stage company developing a gene therapy for the treatment of heart failure.


Share this:Email this pageShare this on LinkedInShare this on Twitter

BEAT BioTherapeutics

BEAT BioTherapeutics
City: Bellevue
State: Washington
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Biotech Showcase™ 2015
Bell Biosystems, Inc.
Bell Biosystems, Inc.
Palo Alto, California, United States
Bell Biosystems is a pre-clinical synthetic biology company developing living biological tools that add complex function to cells. Its lead product is a living magnetic contra...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Bell Biosystems, Inc.

Bell Biosystems, Inc.
City: Palo Alto
State: California
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Bell Biosystems is a pre-clinical synthetic biology company developing living biological tools that add complex function to cells. Its lead product is a living magnetic contrast agent to address economic and technical roadblocks in the clinical practice of cell therapies.

Visit: http://www.bellbiosystems.com
Connect with Bell Biosystems, Inc. on partnering360®

Biotech Showcase™ 2015
Benitec Biopharma
Benitec Biopharma
(ASX:BLT)
Sydney, New South Wales, Australia
Benitc Biopharma develops treatments for chronic and life-threatening conditions based on its gene-silencing technology. Its clinical pipeline is focused on Hep C, Hep B, lung...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Benitec Biopharma

Benitec Biopharma
City: Sydney
State: New South Wales
Country: Australia
Ownership: PUBLIC
Ticker: BLT
Stock exchange: ASX
Schedule information will be posted soon
Benitc Biopharma develops treatments for chronic and life-threatening conditions based on its gene-silencing technology. Its clinical pipeline is focused on Hep C, Hep B, lung cancer and wet age-related macular degeneration. Its lead candidate targets Hep C and is in Phase1/2a

Visit: http://www.benitec.com
Connect with Benitec Biopharma on partnering360®

Biotech Showcase™ 2015
Bio-Path Holdings, Inc.
Bio-Path Holdings, Inc.
(NASDAQ:BPTH)
Bellaire, Texas, United States
This is a clinical stage company developing therapeutic products using its liposomal delivery technology designed to systemically distribute nucleic acid drugs with a simple i...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Bio-Path Holdings, Inc.

Bio-Path Holdings, Inc.
City: Bellaire
State: Texas
Country: United States
Ownership: PUBLIC
Ticker: BPTH
Stock exchange: NASDAQ
Schedule information will be posted soon
This is a clinical stage company developing therapeutic products using its liposomal delivery technology designed to systemically distribute nucleic acid drugs with a simple intravenous transfusion. Its lead candidate will start a Phase 2 study for blood cancers and is in preclinical studies for triple negative and inflammatory breast cancers.

Visit: http://www.biopathholdings.com
Connect with Bio-Path Holdings, Inc. on partnering360®

Biotech Showcase™ 2015
BioLineRx
BioLineRx
(NASDAQ:BLRX)
Jerusalem, Israel
BioLineRx is a clinical stage biopharmaceutical company that identifies, in-licenses and develops therapeutic candidates. It develops assets through pre-clinical or clinical s...


Share this:Email this pageShare this on LinkedInShare this on Twitter

BioLineRx

BioLineRx
City: Jerusalem
Country: Israel
Ownership: PUBLIC
Ticker: BLRX
Stock exchange: NASDAQ
Schedule information will be posted soon
BioLineRx is a clinical stage biopharmaceutical company that identifies, in-licenses and develops therapeutic candidates. It develops assets through pre-clinical or clinical stages and then partners with pharmaceutical companies for advanced clinical development or commercialization.

Visit: http://www.biolinerx.com
Connect with BioLineRx on partnering360®

Biotech Showcase™ 2015
Biological Dynamics, Inc.
Biological Dynamics, Inc.
San Diego, California, United States
Biological Dynamics is a clinical stage diagnostic company focused on cancer treatment response monitoring. It expects to receive a CE mark and 510k clearance in 2016.


Share this:Email this pageShare this on LinkedInShare this on Twitter

Biological Dynamics, Inc.

Biological Dynamics, Inc.
City: San Diego
State: California
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Biological Dynamics is a clinical stage diagnostic company focused on cancer treatment response monitoring. It expects to receive a CE mark and 510k clearance in 2016.

Visit: http://www.biologicaldynamics.com
Connect with Biological Dynamics, Inc. on partnering360®

Biotech Showcase™ 2015
BioMarker Strategies, LLC
BioMarker Strategies, LLC
Rockville, Maryland, United States



Share this:Email this pageShare this on LinkedInShare this on Twitter

BioMarker Strategies, LLC

BioMarker Strategies, LLC
City: Rockville
State: Maryland
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Biotech Showcase™ 2015
Bionik Laboratories Inc.
Bionik Laboratories Inc.
Toronto, Ontario, Canada
Bionik Laboratories is a clinical stage medical device company developing healthcare solutions for patients with restricted physical mobility. Its lead product is a lo...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Bionik Laboratories Inc.

Bionik Laboratories Inc.
City: Toronto
State: Ontario
Country: Canada
Ownership: PRIVATE
Schedule information will be posted soon
Bionik Laboratories is a clinical stage medical device company developing healthcare solutions for patients with restricted physical mobility. Its lead product is a lower body exoskeleton is in clinical trials now. The company expects to market the product in late 2015 or early 2016.

Visit: http://www.bioniklabs.com
Connect with Bionik Laboratories Inc. on partnering360®

Biotech Showcase™ 2015
Bionomics
Bionomics
(ASX:BNO)
Thebarton, South Australia, Australia
Bionomics is creating new therapies for the treatment of cancer and diseases of the central nervous system such as anxiety, depression and Alzheimer’s based on four platform...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Bionomics

Bionomics
City: Thebarton
State: South Australia
Country: Australia
Ownership: PUBLIC
Ticker: BNO
Stock exchange: ASX
Schedule information will be posted soon
Bionomics is creating new therapies for the treatment of cancer and diseases of the central nervous system such as anxiety, depression and Alzheimer’s based on four platform technologies. Its lead candidate is a solid tumor targeting agent in Phase 2 trials.

Visit: http://www.bionomics.com.au
Connect with Bionomics on partnering360®

Biotech Showcase™ 2015
Bionure Inc
Bionure Inc
Menlo Park, California, United States
Bionure is a late-pre-clinical stage company developing SGK agonists for the treatment of orphan ophthalmologic diseases. Its lead candidate has been designated orphan for the...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Bionure Inc

Bionure Inc
City: Menlo Park
State: California
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Bionure is a late-pre-clinical stage company developing SGK agonists for the treatment of orphan ophthalmologic diseases. Its lead candidate has been designated orphan for the treatment of optic neuritis. And IND is expected in Q2 2015.

Visit: http://www.bionure.com
Connect with Bionure Inc on partnering360®

Biotech Showcase™ 2015
Biotecnol Ltd
Biotecnol Ltd
Welwyn Garden City, United Kingdom
Biotecnol is a pre-clinical stage company developing T and NK-cell activating, multi-targeting antibodies in the immune-oncology field.


Share this:Email this pageShare this on LinkedInShare this on Twitter

Biotecnol Ltd

Biotecnol Ltd
City: Welwyn Garden City
Country: United Kingdom
Ownership: PRIVATE
Schedule information will be posted soon
Biotecnol is a pre-clinical stage company developing T and NK-cell activating, multi-targeting antibodies in the immune-oncology field.

Visit: http://www.biotecnol.com
Connect with Biotecnol Ltd on partnering360®

Biotech Showcase™ 2015
Biotron Limited
Biotron Limited
(ASX:BIT)
Sydney, New South Wales, Australia
Biotron is a mid-stage drug development company targeting Hepatitis C and HIV. Its small molecule antiviral drug has shown good clinical efficacy against HCV. It has also has ...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Biotron Limited

Biotron Limited
City: Sydney
State: New South Wales
Country: Australia
Ownership: PUBLIC
Ticker: BIT
Stock exchange: ASX
Schedule information will be posted soon
Biotron is a mid-stage drug development company targeting Hepatitis C and HIV. Its small molecule antiviral drug has shown good clinical efficacy against HCV. It has also has potential to attack HIV viral reservoirs which would contribute to the eradication of HIV.

Visit: http://www.biotron.com.au
Connect with Biotron Limited on partnering360®

Biotech Showcase™ 2015
Biovest International, Inc.
Biovest International, Inc.
Minneapolis, Minnesota, United States



Share this:Email this pageShare this on LinkedInShare this on Twitter

Biovest International, Inc.

Biovest International, Inc.
City: Minneapolis
State: Minnesota
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Biotech Showcase™ 2015
Blend Therapeutics
Blend Therapeutics
Hackensack, Massachusetts, United States
Blend Therapeutics develops medicines that overcome the biological barriers that limit the effectiveness of cancer therapeutics. It is advancing a small molecule anticancer dr...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Blend Therapeutics

Blend Therapeutics
City: Hackensack
State: Massachusetts
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Blend Therapeutics develops medicines that overcome the biological barriers that limit the effectiveness of cancer therapeutics. It is advancing a small molecule anticancer drug candidate through pre-clinical development.

Visit: http://www.blendtx.com
Connect with Blend Therapeutics on partnering360®

Biotech Showcase™ 2015
BrainStorm Cell Therapeutics
BrainStorm Cell Therapeutics
(NASDAQ:BCLI)
Hackensack, New Jersey, United States
BrainStorm is a clinical stage company with a technology for cell-based delivery of neurotrophic factors. Its lead product is in a Phase 2 clinical trial at three US centers f...


Share this:Email this pageShare this on LinkedInShare this on Twitter

BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics
City: Hackensack
State: New Jersey
Country: United States
Ownership: PUBLIC
Ticker: BCLI
Stock exchange: NASDAQ
Schedule information will be posted soon
BrainStorm is a clinical stage company with a technology for cell-based delivery of neurotrophic factors. Its lead product is in a Phase 2 clinical trial at three US centers for ALS. It is also targeting Parkinson’s disease, MS and other CNS diseases.

Visit: http://www.brainstorm-cell.com
Connect with BrainStorm Cell Therapeutics on partnering360®

Biotech Showcase™ 2015
C4X Discovery
C4X Discovery
(AIM:C4XD.L)
Manchester, United Kingdom
C4X Discovery is a pre-clinical company with a platform for small molecule discovery that accurately measures the range and shapes a molecule can take in a solution. The platf...


Share this:Email this pageShare this on LinkedInShare this on Twitter

C4X Discovery

C4X Discovery
City: Manchester
Country: United Kingdom
Ownership: PUBLIC
Ticker: C4XD.L
Stock exchange: AIM
Schedule information will be posted soon
C4X Discovery is a pre-clinical company with a platform for small molecule discovery that accurately measures the range and shapes a molecule can take in a solution. The platform is indication independent, however the company is targeting addition, diabetes and COPD. It has collaborations with AZ, Takeda and Evotec.

Visit: http://www.c4xdiscovery.com
Connect with C4X Discovery on partnering360®

Biotech Showcase™ 2015
Canbex Therapeutics
Canbex Therapeutics
London, United Kingdom
Canbex Therapeutics has a Phase 2 ready compound that it hopes will be the first well-tolerated treatment for uncontrolled muscle movement in multiple sclerosis and other diso...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Canbex Therapeutics

Canbex Therapeutics
City: London
Country: United Kingdom
Ownership: PRIVATE
Schedule information will be posted soon
Canbex Therapeutics has a Phase 2 ready compound that it hopes will be the first well-tolerated treatment for uncontrolled muscle movement in multiple sclerosis and other disorders. The compound is an orally-active small molecule.

Visit: http://www.canbex.co.uk
Connect with Canbex Therapeutics on partnering360®

Biotech Showcase™ 2015
Capricor Therapeutics, Inc,
Capricor Therapeutics, Inc,
(CAPR:OTCQB)
Beverly Hills, California, United States
Capricor develops therapeutics for the treatment of cardiovascular disease. Its lead product is an allogeneic adult stem cell therapy for heart disease that is in Phase 2 in i...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Capricor Therapeutics, Inc,

Capricor Therapeutics, Inc,
City: Beverly Hills
State: California
Country: United States
Ownership: PUBLIC
Ticker: OTCQB
Stock exchange: CAPR
Schedule information will be posted soon
Capricor develops therapeutics for the treatment of cardiovascular disease. Its lead product is an allogeneic adult stem cell therapy for heart disease that is in Phase 2 in ischemic heart disease and Duchenne Muscular Dystrophy.

Visit: http://www.capricor.com
Connect with Capricor Therapeutics, Inc, on partnering360®

Biotech Showcase™ 2015
CEL-SCI Corporation
CEL-SCI Corporation
(NYSE-M:CVM)
Vienna, Virginia, United States
CEL-SCI is an advanced stage immunotherapy company with platform technologies that can potentially treat a variety of cancers and viral diseases. It is currently conducting a ...


Share this:Email this pageShare this on LinkedInShare this on Twitter

CEL-SCI Corporation

CEL-SCI Corporation
City: Vienna
State: Virginia
Country: United States
Ownership: PUBLIC
Ticker: CVM
Stock exchange: NYSE-M
Schedule information will be posted soon
CEL-SCI is an advanced stage immunotherapy company with platform technologies that can potentially treat a variety of cancers and viral diseases. It is currently conducting a Phase 3 trial for the treatment of head and neck cancer and a Phase 1 study with the US Navy in HIV/HPV co-infected patients.

Visit: http://www.cel-sci.com
Connect with CEL-SCI Corporation on partnering360®

Biotech Showcase™ 2015
Cell Source Ltd.
Cell Source Ltd.
(OTCQB:CLCS)
Tel Aviv, Israel
Cell Source is a pre-clinical stage immunotherapy and regenerative medicine company. Its technology relates to the regulation of immune tolerance to effectively treat ...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Cell Source Ltd.

Cell Source Ltd.
City: Tel Aviv
Country: Israel
Ownership: PUBLIC
Ticker: CLCS
Stock exchange: OTCQB
Schedule information will be posted soon
Cell Source is a pre-clinical stage immunotherapy and regenerative medicine company. Its technology relates to the regulation of immune tolerance to effectively treat blood cancers and nonmalignant congenital diseases.

Visit: http://www.cell-source.com
Connect with Cell Source Ltd. on partnering360®

Biotech Showcase™ 2015
Cell Therapy Limited
Cell Therapy Limited
Cardiff, United Kingdom
Cell Therapy is a clinical stage cell therapy company that has completed a Phase 2a trial demonstrating in situ myocardial regeneration with clinical and statistically signifi...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Cell Therapy Limited

Cell Therapy Limited
City: Cardiff
Country: United Kingdom
Ownership: PRIVATE
Schedule information will be posted soon
Cell Therapy is a clinical stage cell therapy company that has completed a Phase 2a trial demonstrating in situ myocardial regeneration with clinical and statistically significant improvement in LVEF, scar reduction and improved quality of life.

Visit: http://www.celltherapyltd.com
Connect with Cell Therapy Limited on partnering360®

Biotech Showcase™ 2015
Cellceutix
Cellceutix
(OTC:CTIX)
Beverly, Massachusetts, United States
Cellceutix is a therapeutic antibody company that recently completed a Phase 2 study. The company has compounds in clinical trials for cancers, psoriasis and oral mucositis. A...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Cellceutix

Cellceutix
City: Beverly
State: Massachusetts
Country: United States
Ownership: PUBLIC
Ticker: CTIX
Stock exchange: OTC
Schedule information will be posted soon
Cellceutix is a therapeutic antibody company that recently completed a Phase 2 study. The company has compounds in clinical trials for cancers, psoriasis and oral mucositis. Additional trials are planned for diabetic foot infections, eye and ear infections, anti-fungal and gram-negative drug resistant bacteria.

Visit: http://www.cellceutix.com
Connect with Cellceutix on partnering360®

Biotech Showcase™ 2015
Cellectar Biosciences
Cellectar Biosciences
(NASDAQ:CLRB)
Madison, Wisconsin, United States
Cellectar Biosciences is a clinical stage oncology company that uses a technology that permits selective delivery of a variety of agents to cancer cells. Its lead candidate is...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Cellectar Biosciences

Cellectar Biosciences
City: Madison
State: Wisconsin
Country: United States
Ownership: PUBLIC
Ticker: CLRB
Stock exchange: NASDAQ
Schedule information will be posted soon
Cellectar Biosciences is a clinical stage oncology company that uses a technology that permits selective delivery of a variety of agents to cancer cells. Its lead candidate is a Phase 2 small molecule currently being evaluated in patients with glioblastoma.

Visit: http://www.cellectar.com
Connect with Cellectar Biosciences on partnering360®

Biotech Showcase™ 2015
Cellular Biomedicine Group Inc.
Cellular Biomedicine Group Inc.
(NASDAQ:CBMG)
Palo Alto, California, United States
Cellular Biomedicine is a clinical stage regenerative medicine and immune cell company with operations in China. It is aging diseases and cancer in the Chinese market and expe...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Cellular Biomedicine Group Inc.

Cellular Biomedicine Group Inc.
City: Palo Alto
State: California
Country: United States
Ownership: PUBLIC
Ticker: CBMG
Stock exchange: NASDAQ
Schedule information will be posted soon
Cellular Biomedicine is a clinical stage regenerative medicine and immune cell company with operations in China. It is aging diseases and cancer in the Chinese market and expects to have Phase 2a interim data on its lead product for knee osteoarthritis in Q1 2015.
Connect with Cellular Biomedicine Group Inc. on partnering360®

Biotech Showcase™ 2015
CereSpir, Incorporated
CereSpir, Incorporated
New York, New York, United States
CereSpir’s lead product has completed a Phase 2 study in people with mild cognitive impairment, and the company is currently finalizing the design of the Phase 3 clinical pr...


Share this:Email this pageShare this on LinkedInShare this on Twitter

CereSpir, Incorporated

CereSpir, Incorporated
City: New York
State: New York
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
CereSpir’s lead product has completed a Phase 2 study in people with mild cognitive impairment, and the company is currently finalizing the design of the Phase 3 clinical protocol in consultation with KOLs and the FDA. It aims to initiate Phase 3 trials in 2015.

Visit: http://www.cerespir.com
Connect with CereSpir, Incorporated on partnering360®

Biotech Showcase™ 2015
Cesca Therapeuticss
Cesca Therapeuticss
(NASDAQ:KOOL)
Rancho Cordova, California, United States



Share this:Email this pageShare this on LinkedInShare this on Twitter

Cesca Therapeuticss

Cesca Therapeuticss
City: Rancho Cordova
State: California
Country: United States
Ownership: PUBLIC
Ticker: KOOL
Stock exchange: NASDAQ
Schedule information will be posted soon
Biotech Showcase™ 2015
CEVEC
CEVEC
Cologne, Germany
CEVEC is a clinical stage company developing CAP-based treatments for various indications including inherited angioedema, lung emphysema and inflammatory diseases.


Share this:Email this pageShare this on LinkedInShare this on Twitter

CEVEC

CEVEC
City: Cologne
Country: Germany
Ownership: PRIVATE
Schedule information will be posted soon
CEVEC is a clinical stage company developing CAP-based treatments for various indications including inherited angioedema, lung emphysema and inflammatory diseases.

Visit: http://www.cevec.com
Connect with CEVEC on partnering360®

Biotech Showcase™ 2015
Chembio Diagnostics, Inc.
Chembio Diagnostics, Inc.
(NASDAQ:CEMI)
Medford, New York, United States
Chembio is a commercial stage company that develops, manufactures, licenses and markets rapid diagnostic tests in the point-of-care testing market. It markets a branded test f...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Chembio Diagnostics, Inc.

Chembio Diagnostics, Inc.
City: Medford
State: New York
Country: United States
Ownership: PUBLIC
Ticker: CEMI
Stock exchange: NASDAQ
Schedule information will be posted soon
Chembio is a commercial stage company that develops, manufactures, licenses and markets rapid diagnostic tests in the point-of-care testing market. It markets a branded test for HIV and is developing diagnostic tests for Ebola, dengue fever and a specific cancer.

Visit: http://www.chembio.com
Connect with Chembio Diagnostics, Inc. on partnering360®

Biotech Showcase™ 2015
Chronos Therapeutics Ltd
Chronos Therapeutics Ltd
Oxford, United Kingdom
Chronos is a clinical stage company focused on disease of aging, neurodegeneration and osteoporosis. Its lead compound with target indications for osteoporosis and ALS is in P...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Chronos Therapeutics Ltd

Chronos Therapeutics Ltd
City: Oxford
Country: United Kingdom
Ownership: PRIVATE
Schedule information will be posted soon
Chronos is a clinical stage company focused on disease of aging, neurodegeneration and osteoporosis. Its lead compound with target indications for osteoporosis and ALS is in Phase 2 a/b clinical trials.

Visit: http://www.chronostherapeutics.com
Connect with Chronos Therapeutics Ltd on partnering360®

Biotech Showcase™ 2015
ContraFect Corporation
ContraFect Corporation
(NASDAQ:CFRX)
Yonkers, New York, United States
ContraFect is a preclinical biopharmaceutical company that discovers and develops therapeutic protein and antibody products for drug-resistant infectious diseases. It uses lys...


Share this:Email this pageShare this on LinkedInShare this on Twitter

ContraFect Corporation

ContraFect Corporation
City: Yonkers
State: New York
Country: United States
Ownership: PUBLIC
Ticker: CFRX
Stock exchange: NASDAQ
Schedule information will be posted soon
ContraFect is a preclinical biopharmaceutical company that discovers and develops therapeutic protein and antibody products for drug-resistant infectious diseases. It uses lysine and antibody platforms to target conserved regions of either bacteria or viruses.

Visit: http://www.contrafect.com
Connect with ContraFect Corporation on partnering360®

Biotech Showcase™ 2015
Contravir Pharmaceuticals
Contravir Pharmaceuticals
(OTCBB:CTRV)
Edison, New Jersey, United States
ContraVir is a development stage biopharmaceutical company that discovers and develops targeted antiviral therapies. Its lead candidate is an orally available treatment for he...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Contravir Pharmaceuticals

Contravir Pharmaceuticals
City: Edison
State: New Jersey
Country: United States
Ownership: PUBLIC
Ticker: CTRV
Stock exchange: OTCBB
Schedule information will be posted soon
ContraVir is a development stage biopharmaceutical company that discovers and develops targeted antiviral therapies. Its lead candidate is an orally available treatment for herpes zoster, or shingles, that is in Phsase 2b clinical trials.

Visit: http://www.contravir.com
Connect with Contravir Pharmaceuticals on partnering360®

Biotech Showcase™ 2015
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc.
(OTCQB:CRBP)
Norwood, Massachusetts, United States
Corbus is a clinical stage biopharmaceutical company that develops therapies to treat inflammatory-fibrotic diseases with clear unmet needs. Its lead product candidate, an ora...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Corbus Pharmaceuticals, Inc.

Corbus Pharmaceuticals, Inc.
City: Norwood
State: Massachusetts
Country: United States
Ownership: PUBLIC
Ticker: CRBP
Stock exchange: OTCQB
Schedule information will be posted soon
Corbus is a clinical stage biopharmaceutical company that develops therapies to treat inflammatory-fibrotic diseases with clear unmet needs. Its lead product candidate, an oral anti-inflammatory drug, is scheduled to start Phase 2a trials for cystic fibrosis and systemic scleroderma in 2015.

Visit: http://www.corbuspharma.com
Connect with Corbus Pharmaceuticals, Inc. on partnering360®

Biotech Showcase™ 2015
Cornerstone Pharmaceuticals Inc.
New York, New York, United States
This clinical stage, oncology-focused pharmaceutical company has a platform that targets and disrupts energy metabolism in cancer cells. Its lead product is in clinical trials...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Cornerstone Pharmaceuticals Inc.

City: New York
State: New York
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
This clinical stage, oncology-focused pharmaceutical company has a platform that targets and disrupts energy metabolism in cancer cells. Its lead product is in clinical trials for solid tumors and hematologic malignancies.

Visit: http://www.cornerstonepharma.com/
Connect with Cornerstone Pharmaceuticals Inc. on partnering360®

Biotech Showcase™ 2015
Cortendo AB
Cortendo AB
(OTC:CRTOF)
Radnor, Pennsylvania, United States
Cortendo commercializes medicines for orphan endocrine disorders. Its lead product is currently being studied in a Phase 3 global trial for the treatment of Cushing’s syndro...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Cortendo AB

Cortendo AB
City: Radnor
State: Pennsylvania
Country: United States
Ownership: PUBLIC
Ticker: CRTOF
Stock exchange: OTC
Schedule information will be posted soon
Cortendo commercializes medicines for orphan endocrine disorders. Its lead product is currently being studied in a Phase 3 global trial for the treatment of Cushing’s syndrome.

Visit: http://www.cortendo.com/
Connect with Cortendo AB on partnering360®

Biotech Showcase™ 2015
Cortex Pharmaceuticals Inc.
Cortex Pharmaceuticals Inc.
(OTCBB:CORX)
Glen Rock, New Jersey, United States



Share this:Email this pageShare this on LinkedInShare this on Twitter

Cortex Pharmaceuticals Inc.

Cortex Pharmaceuticals Inc.
City: Glen Rock
State: New Jersey
Country: United States
Ownership: PUBLIC
Ticker: CORX
Stock exchange: OTCBB
Schedule information will be posted soon
Biotech Showcase™ 2015
Cortice Biosciences
Cortice Biosciences
New York, New York, United States
Cortice Biosciences is a clinical stage company developing treatments for large and rare oncologic and neurologic disease indications. Its lead programs address the treatment ...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Cortice Biosciences

Cortice Biosciences
City: New York
State: New York
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Cortice Biosciences is a clinical stage company developing treatments for large and rare oncologic and neurologic disease indications. Its lead programs address the treatment of brain cancers and neurodegenerative diseases and neurotransmitter pathway modulation for the treatment of cognitive impairment.

Visit: http://www.corticebiosciences.com
Connect with Cortice Biosciences on partnering360®

Biotech Showcase™ 2015
Crescendo Biologics Ltd
Crescendo Biologics Ltd
Cambridge, United Kingdom
Crescendo Biologics is a preclinical company that has developed an antibody fragment platform. It has recently completed a Series A financing that will allow it to develop a t...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Crescendo Biologics Ltd

Crescendo Biologics Ltd
City: Cambridge
Country: United Kingdom
Ownership: PRIVATE
Schedule information will be posted soon
Crescendo Biologics is a preclinical company that has developed an antibody fragment platform. It has recently completed a Series A financing that will allow it to develop a topical biologic for psoriasis and as well as discovery phase oncology products.

Visit: http://www.crescendobiologics.com
Connect with Crescendo Biologics Ltd on partnering360®

Biotech Showcase™ 2015
Cristal Therapeutics
Cristal Therapeutics
maastricht, Netherlands



Share this:Email this pageShare this on LinkedInShare this on Twitter

Cristal Therapeutics

Cristal Therapeutics
City: maastricht
Country: Netherlands
Schedule information will be posted soon
Biotech Showcase™ 2015
Critical Outcome Technologies Inc.
Critical Outcome Technologies Inc.
(TSX-V:COT)
London, Ontario, Canada



Share this:Email this pageShare this on LinkedInShare this on Twitter

Critical Outcome Technologies Inc.

Critical Outcome Technologies Inc.
City: London
State: Ontario
Country: Canada
Ownership: PUBLIC
Ticker: COT
Stock exchange: TSX-V
Schedule information will be posted soon
Biotech Showcase™ 2015
Cyclacel Pharmaceuticals, Inc.
Cyclacel Pharmaceuticals, Inc.
(NASDAQ:CYCC)
Berkeley Heights, New Jersey, United States
Cyclacel’s lead drug candidate in a Phase 3 trial that is now over 90% enrolled and is being conducted under an SPA with the FDA as a front-line treatment for AML in the eld...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Cyclacel Pharmaceuticals, Inc.

Cyclacel Pharmaceuticals, Inc.
City: Berkeley Heights
State: New Jersey
Country: United States
Ownership: PUBLIC
Ticker: CYCC
Stock exchange: NASDAQ
Schedule information will be posted soon
Cyclacel’s lead drug candidate in a Phase 3 trial that is now over 90% enrolled and is being conducted under an SPA with the FDA as a front-line treatment for AML in the elderly. The drug is also being studied for MDS and solid tumors in combination with its CDK inhibitor.

Visit: http://www.cyclacel.com
Connect with Cyclacel Pharmaceuticals, Inc. on partnering360®

Biotech Showcase™ 2015
Cynapsus Therapeutics Inc
Cynapsus Therapeutics Inc
(OTCQB:CYNAF)
Toronto, Ontario, Canada
Cynapsus is a specialty pharmaceutical company developing a sublingual thin film strip for the acute rescue of ‘off’ motor symptoms of Parkinson’s disease. Its lead cand...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Cynapsus Therapeutics Inc

Cynapsus Therapeutics Inc
City: Toronto
State: Ontario
Country: Canada
Ownership: PUBLIC
Ticker: CYNAF
Stock exchange: OTCQB
Schedule information will be posted soon
Cynapsus is a specialty pharmaceutical company developing a sublingual thin film strip for the acute rescue of ‘off’ motor symptoms of Parkinson’s disease. Its lead candidate is a reformulation of the only approved drug to rescue patients from ‘off’ episodes. It expects to submit an NDA in 2016.

Visit: http://www.cynapsus.ca
Connect with Cynapsus Therapeutics Inc on partnering360®

Biotech Showcase™ 2015
Cytograft
Cytograft
Novato, California, United States
Cytograft is a late stage regenerative medicine and tissue engineering company. It currently has three programs in human clinical trials: Phase 2b/3 vascular graft for hemodia...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Cytograft

Cytograft
City: Novato
State: California
Country: United States
Ownership: PUBLIC
Ticker:
Stock exchange:
Schedule information will be posted soon
Cytograft is a late stage regenerative medicine and tissue engineering company. It currently has three programs in human clinical trials: Phase 2b/3 vascular graft for hemodialysis access; Phase 1/2 vascular graft for lower limb bypass; Phase 1/2 dermal filler for smile lines and facial wrinkles.

Visit: http://www.cytograft.com
Connect with Cytograft on partnering360®

Biotech Showcase™ 2015
Cytori Therapeutics, Inc.
Cytori Therapeutics, Inc.
(NASDAQ:CYTX)
San Diego, California, United States
Cytori is a clinical stage cell therapy company developing treatments for cardiovascular disease and soft tissue injuries and burns. It is targeting the treatment of chronic i...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Cytori Therapeutics, Inc.

Cytori Therapeutics, Inc.
City: San Diego
State: California
Country: United States
Ownership: PUBLIC
Ticker: CYTX
Stock exchange: NASDAQ
Schedule information will be posted soon
Cytori is a clinical stage cell therapy company developing treatments for cardiovascular disease and soft tissue injuries and burns. It is targeting the treatment of chronic ischemic heart failure through internal clinical development efforts and to develop a treatment for thermal burns combined with radiation injury under a contract from BARDA.

Visit: http://www.cytori.com
Connect with Cytori Therapeutics, Inc. on partnering360®

Biotech Showcase™ 2015
DARA BioSciences, Inc.
DARA BioSciences, Inc.
(NASDAQ:DARA)
Raleigh, North Carolina, United States
DARA Biosciences is a commercialized oncology supportive care pharmaceutical company that offers a synergistic portfolio of medicines to help cancer patients adhere to their t...


Share this:Email this pageShare this on LinkedInShare this on Twitter

DARA BioSciences, Inc.

DARA BioSciences, Inc.
City: Raleigh
State: North Carolina
Country: United States
Ownership: PUBLIC
Ticker: DARA
Stock exchange: NASDAQ
Schedule information will be posted soon
DARA Biosciences is a commercialized oncology supportive care pharmaceutical company that offers a synergistic portfolio of medicines to help cancer patients adhere to their therapy and manage the side effects of treatment.

Visit: http://www.darabio.com
Connect with DARA BioSciences, Inc. on partnering360®

Biotech Showcase™ 2015
Dipexium Pharmaceuticals
Dipexium Pharmaceuticals
(NASDAQ:DPRX)
New York, New York, United States
Dipexium is conducting pivotal Phase 3 trials on its topical antibiotic cream targeting the treatment of mild infections of diabetic foot ulcers as well as other skin infectio...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Dipexium Pharmaceuticals

Dipexium Pharmaceuticals
City: New York
State: New York
Country: United States
Ownership: PUBLIC
Ticker: DPRX
Stock exchange: NASDAQ
Schedule information will be posted soon
Dipexium is conducting pivotal Phase 3 trials on its topical antibiotic cream targeting the treatment of mild infections of diabetic foot ulcers as well as other skin infections including those caused by resistant bacteria or ‘superbugs.’

Visit: http://www.dipexiumpharmaceuticals.com
Connect with Dipexium Pharmaceuticals on partnering360®

Biotech Showcase™ 2015
Elastagen Pty Ltd
Elastagen Pty Ltd
Sydney, New South Wales, Australia



Share this:Email this pageShare this on LinkedInShare this on Twitter

Elastagen Pty Ltd

Elastagen Pty Ltd
City: Sydney
State: New South Wales
Country: Australia
Ownership: PRIVATE
Schedule information will be posted soon
Biotech Showcase™ 2015
Ellume
Ellume
East Brisbane, Queensland, Australia



Share this:Email this pageShare this on LinkedInShare this on Twitter

Ellume

Ellume
City: East Brisbane
State: Queensland
Country: Australia
Ownership: PRIVATE
Schedule information will be posted soon
Biotech Showcase™ 2015
Embera NeuroTherapeutics
Embera NeuroTherapeutics
Sudbury, Massachusetts, United States
Embera is developing a patented drug combination to address smoking cessation and cocaine dependence. The FDA has completed its review of the company’s IND submission and a ...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Embera NeuroTherapeutics

Embera NeuroTherapeutics
City: Sudbury
State: Massachusetts
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Embera is developing a patented drug combination to address smoking cessation and cocaine dependence. The FDA has completed its review of the company’s IND submission and a Phase 1 study in otherwise health smokers is set to proceed.

Visit: http://www.emberaneuro.com
Connect with Embera NeuroTherapeutics on partnering360®

Biotech Showcase™ 2015
EnGeneIC Ltd
EnGeneIC Ltd
Lane Cove West, New South Wales, Australia
EnGeneIC Limited is a clinical stage biopharmaceutical company that aims to commercialize products for the targeted delivery of drugs and functional nucleic acids used...


Share this:Email this pageShare this on LinkedInShare this on Twitter

EnGeneIC Ltd

EnGeneIC Ltd
City: Lane Cove West
State: New South Wales
Country: Australia
Ownership: PRIVATE
Schedule information will be posted soon
EnGeneIC Limited is a clinical stage biopharmaceutical company that aims to commercialize products for the targeted delivery of drugs and functional nucleic acids used in the treatment of cancer.

Visit: http://www.engeneic.com
Connect with EnGeneIC Ltd on partnering360®

Biotech Showcase™ 2015
Ennaid Therapeutics
Ennaid Therapeutics
New York, New York, United States
Ennaid Therapeutics is a preclinical company that is developing cures for dengue virus, a mosquito-borne disease. The company expects that with its fast track developm...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Ennaid Therapeutics

Ennaid Therapeutics
City: New York
State: New York
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Ennaid Therapeutics is a preclinical company that is developing cures for dengue virus, a mosquito-borne disease. The company expects that with its fast track development program its lead product will be on the market in 4 to 6 years.

Visit: http://www.ennaidthera.com
Connect with Ennaid Therapeutics on partnering360®

Biotech Showcase™ 2015
Enumeral
Enumeral
(OTCQB:ENUM)
Cambridge, Massachusetts, United States
Enumeral is a preclinical stage company developing antibody immunotherapies for cancer, inflammatory and autoimmune diseases. Its platform enables the measurement of d...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Enumeral

Enumeral
City: Cambridge
State: Massachusetts
Country: United States
Ownership: PUBLIC
Ticker: ENUM
Stock exchange: OTCQB
Schedule information will be posted soon
Enumeral is a preclinical stage company developing antibody immunotherapies for cancer, inflammatory and autoimmune diseases. Its platform enables the measurement of drug effects in a patient-specific manner.

Visit: http://www.enumeral.com
Connect with Enumeral on partnering360®

Biotech Showcase™ 2015
Epirus Biopharmaceuticals
Boston, Massachusetts, United States



Share this:Email this pageShare this on LinkedInShare this on Twitter

Epirus Biopharmaceuticals

City: Boston
State: Massachusetts
Country: United States
Schedule information will be posted soon
Biotech Showcase™ 2015
Etubics Corporation
Etubics Corporation
Seattle, Washington, United States
Etubics is a clinical stage company with immunotherapy programs oncology and infectious diseases including Ebola, universal influenza and Lassa. Its platform technology has br...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Etubics Corporation

Etubics Corporation
City: Seattle
State: Washington
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Etubics is a clinical stage company with immunotherapy programs oncology and infectious diseases including Ebola, universal influenza and Lassa. Its platform technology has broad applications to induce cell mediated and antibody responses and allows for rapid development vaccines.

Visit: http://www.etubics.com
Connect with Etubics Corporation on partnering360®

Biotech Showcase™ 2015
Fate Therapeutics, Inc.
Fate Therapeutics, Inc.
(NASDAQ:FATE)
San Diego, California, United States
Fate is a clinical stage biopharmaceutical company that discovers and develops pharmacologic modulators of adult stem cells to treat life-threatening diseases. It’s ...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Fate Therapeutics, Inc.

Fate Therapeutics, Inc.
City: San Diego
State: California
Country: United States
Ownership: PUBLIC
Ticker: FATE
Stock exchange: NASDAQ
Schedule information will be posted soon
Fate is a clinical stage biopharmaceutical company that discovers and develops pharmacologic modulators of adult stem cells to treat life-threatening diseases. It’s leading candidate in a Phase 2 clinical trials.
Connect with Fate Therapeutics, Inc. on partnering360®

Biotech Showcase™ 2015
Fibrocell Science
Fibrocell Science
(NASDAQ:FCSC)
Exton, Pennsylvania, United States
Fibrocell is a clinical stage company that uses autologous fibroblasts to treat rare skin diseases. Its lead orphan candidate uses genetically-modified fibroblasts is ...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Fibrocell Science

Fibrocell Science
City: Exton
State: Pennsylvania
Country: United States
Ownership: PUBLIC
Ticker: FCSC
Stock exchange: NASDAQ
Schedule information will be posted soon
Fibrocell is a clinical stage company that uses autologous fibroblasts to treat rare skin diseases. Its lead orphan candidate uses genetically-modified fibroblasts is in late stage preclinical development for recessive dystrophic epidermolysis bullosa. A Phase 2 for a second compound is in progress for vocal cord scarring.

Visit: http://www.fibrocellscience.com
Connect with Fibrocell Science on partnering360®

Biotech Showcase™ 2015
FLAG Therapeutics
FLAG Therapeutics
Raleigh, North Carolina, United States
FLAG is a preclinical company with 2 classes of small molecule oncology therapeutics. One has both broad antiangiogenic inhibition and anticancer effects and is being ...


Share this:Email this pageShare this on LinkedInShare this on Twitter

FLAG Therapeutics

FLAG Therapeutics
City: Raleigh
State: North Carolina
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
FLAG is a preclinical company with 2 classes of small molecule oncology therapeutics. One has both broad antiangiogenic inhibition and anticancer effects and is being developed as a treatment of glioblastoma. The class is selective to the FR-Alpha receptor which is unique to certain ovarian, NSCLC, colon and kidney cancers.

Visit: http://www.FlagTherapeutics.com
Connect with FLAG Therapeutics on partnering360®

Biotech Showcase™ 2015
Fusion Pharmaceuticals
Fusion Pharmaceuticals
Hamilton, Ontario, Canada
Fusion Pharmaceuticals is a clinical stage company developing precision radiopharmaceuticals for the diagnosis and treatment of human cancers that are currently untrea...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Fusion Pharmaceuticals

Fusion Pharmaceuticals
City: Hamilton
State: Ontario
Country: Canada
Ownership: PRIVATE
Schedule information will be posted soon
Fusion Pharmaceuticals is a clinical stage company developing precision radiopharmaceuticals for the diagnosis and treatment of human cancers that are currently untreatable. Its lead product combines an alpha radionuclide with the precise targeting of an antibody to cause selective cytotoxicity of tumor cells.

Visit: http://www.fusionpharma.com
Connect with Fusion Pharmaceuticals on partnering360®

Biotech Showcase™ 2015
Galmed Pharmaceuticals
Galmed Pharmaceuticals
(NASDAQ:GLMD)
Tel Aviv, Israel
Galmed is a clinical stage biopharmaceutical company developing and commercializing a once-daily, oral therapy for the treatment of liver disease. Its lead product is in Phase...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Galmed Pharmaceuticals

Galmed Pharmaceuticals
City: Tel Aviv
Country: Israel
Ownership: PUBLIC
Ticker: GLMD
Stock exchange: NASDAQ
Schedule information will be posted soon
Galmed is a clinical stage biopharmaceutical company developing and commercializing a once-daily, oral therapy for the treatment of liver disease. Its lead product is in Phase 2b clinical trials.

Visit: http://www.galmedpharma.com
Connect with Galmed Pharmaceuticals on partnering360®

Biotech Showcase™ 2015
Genomic Expression
Genomic Expression
New York, New York, United States



Share this:Email this pageShare this on LinkedInShare this on Twitter

Genomic Expression

Genomic Expression
City: New York
State: New York
Country: United States
Schedule information will be posted soon
Biotech Showcase™ 2015
GICARE PHARMA INC
GICARE PHARMA INC
Montreal-Ouest, Quebec, Canada



Share this:Email this pageShare this on LinkedInShare this on Twitter

GICARE PHARMA INC

GICARE PHARMA INC
City: Montreal-Ouest
State: Quebec
Country: Canada
Ownership: PRIVATE
Schedule information will be posted soon
Biotech Showcase™ 2015
Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc.
South San Francisco, California, United States
GBT is a preclinical stage biopharmaceutical company developing orally available small molecules for the treatment of severe chronic blood diseases. The company expects to ini...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Global Blood Therapeutics, Inc.

Global Blood Therapeutics, Inc.
City: South San Francisco
State: California
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
GBT is a preclinical stage biopharmaceutical company developing orally available small molecules for the treatment of severe chronic blood diseases. The company expects to initiate clinical testing in January 2015.

Visit: http://www.globalbloodtx.com
Connect with Global Blood Therapeutics, Inc. on partnering360®

Biotech Showcase™ 2015
GO Therapeutics
GO Therapeutics
Natick, Massachusetts, United States
GO Therapeutics uses technologies and platforms to harness the cancer glycoporteome to generate tumor-specific antibodies for immunotherapies. By making antibodies to hybrid a...


Share this:Email this pageShare this on LinkedInShare this on Twitter

GO Therapeutics

GO Therapeutics
City: Natick
State: Massachusetts
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
GO Therapeutics uses technologies and platforms to harness the cancer glycoporteome to generate tumor-specific antibodies for immunotherapies. By making antibodies to hybrid antigens combining a tumor’s up-regulated protein express with that of a protein’s aberrant glycosylation pattern, it increases the tumor specificity of therapeutic antibodies.

Visit: http://www.gotherapeutics.com
Connect with GO Therapeutics on partnering360®

Biotech Showcase™ 2015
Gordian Biotechnologies, Inc.
Gordian Biotechnologies, Inc.
West Palm Beach, Florida, United States
Gordian Biotechnologies is a preclinical stage company addressing antibiotic resistance by developing a reversible beta-lactamase inhibitor. Its lead product attacks the resis...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Gordian Biotechnologies, Inc.

Gordian Biotechnologies, Inc.
City: West Palm Beach
State: Florida
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Gordian Biotechnologies is a preclinical stage company addressing antibiotic resistance by developing a reversible beta-lactamase inhibitor. Its lead product attacks the resistance mechanism of bacteria making them once again susceptible to existing antibiotics.

Visit: http://www.gordianbio.com
Connect with Gordian Biotechnologies, Inc. on partnering360®

Biotech Showcase™ 2015
Helomics Corporation
Pittsburgh, Pennsylvania, United States
Helomics is a commercialized personalized healthcare company in the oncology market. In additional to personalized medicine in cancer products, it offers laboratory services i...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Helomics Corporation

City: Pittsburgh
State: Pennsylvania
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Helomics is a commercialized personalized healthcare company in the oncology market. In additional to personalized medicine in cancer products, it offers laboratory services including CRO, bioinformatics/databases and companion diagnostics.

Visit: http://www.helomics.com
Connect with Helomics Corporation on partnering360®

Biotech Showcase™ 2015
Histogen, Inc.
Histogen, Inc.
San Diego, California, United States
Histogen is a commercialized regenerative medicine company using naturally-secreted growth factors and proteins to stimulate the body’s stem cells to regenerate tissue. It i...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Histogen, Inc.

Histogen, Inc.
City: San Diego
State: California
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Histogen is a commercialized regenerative medicine company using naturally-secreted growth factors and proteins to stimulate the body’s stem cells to regenerate tissue. It is targeting oncology, orthopedics, hair growth and aesthetics.

Visit: http://www.histogen.com
Connect with Histogen, Inc. on partnering360®

Biotech Showcase™ 2015
Hydra Biosciences
Hydra Biosciences
Cambridge, Massachusetts, United States
Hydra Biosciences is a clinical stage company that uses TRP ion channels to discover and develop medicines for people with serious diseases. Its most advanced product is being...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Hydra Biosciences

Hydra Biosciences
City: Cambridge
State: Massachusetts
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Hydra Biosciences is a clinical stage company that uses TRP ion channels to discover and develop medicines for people with serious diseases. Its most advanced product is being studied for neuropathic pain and asthma, and it expects to begin human clinical trials in the first half of 2015.

Visit: http://www.hydrabio.com
Connect with Hydra Biosciences on partnering360®

Biotech Showcase™ 2015
iCeutica
iCeutica
King of Prussia, Pennsylvania, United States
This commercial stage company creates branded medicines in the areas of oncology, respiratory disease, musculoskeletal and connective tissue disorders. It has multiple approve...


Share this:Email this pageShare this on LinkedInShare this on Twitter

iCeutica

iCeutica
City: King of Prussia
State: Pennsylvania
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
This commercial stage company creates branded medicines in the areas of oncology, respiratory disease, musculoskeletal and connective tissue disorders. It has multiple approved products and several products in various stages of clinical development.

Visit: http://www.iceutica.com
Connect with iCeutica on partnering360®

Biotech Showcase™ 2015
IGXBio
IGXBio
Lenexa, Kansas, United States
IGXBio is a clinical stage company targeting infectious diseases. The company has an approved IND with the FDA for a Phase 1/2 clinical trial in HIV infected patients.


Share this:Email this pageShare this on LinkedInShare this on Twitter

IGXBio

IGXBio
City: Lenexa
State: Kansas
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
IGXBio is a clinical stage company targeting infectious diseases. The company has an approved IND with the FDA for a Phase 1/2 clinical trial in HIV infected patients.

Visit: http://igxbio.com/
Connect with IGXBio on partnering360®

Biotech Showcase™ 2015
Imanova Ltd
Imanova Ltd
London, United Kingdom



Share this:Email this pageShare this on LinkedInShare this on Twitter

Imanova Ltd

Imanova Ltd
City: London
Country: United Kingdom
Ownership: PRIVATE
Schedule information will be posted soon
Biotech Showcase™ 2015
Immunocore
Immunocore
Abingdon, United Kingdom
Immunocore is a clinical stage company with a platform of bi-specific proteins that has partnerships with Genentech, GSK, Medimmune and Lilly. Its lead product is in Phase 2a ...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Immunocore

Immunocore
City: Abingdon
Country: United Kingdom
Ownership: PRIVATE
Schedule information will be posted soon
Immunocore is a clinical stage company with a platform of bi-specific proteins that has partnerships with Genentech, GSK, Medimmune and Lilly. Its lead product is in Phase 2a trials in patients with metastatic melanoma.

Visit: http://www.immunocore.com
Connect with Immunocore on partnering360®

Biotech Showcase™ 2015
Immunome Inc.
Immunome Inc.
Fort Washington, Pennsylvania, United States
Immunome is a discovery stage company that is using an immunotherapy discovery engine to identify new cancer targets and therapies. The technology platform, co-invented by Rob...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Immunome Inc.

Immunome Inc.
City: Fort Washington
State: Pennsylvania
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Immunome is a discovery stage company that is using an immunotherapy discovery engine to identify new cancer targets and therapies. The technology platform, co-invented by Robert Weinberg at MIT’s Whitehead Institute, has enabled the company to simultaneously discover multiple cancer antigens paired with native human antibodies that attack cancer cells.
Connect with Immunome Inc. on partnering360®

Biotech Showcase™ 2015
Immunomic Therapeutics
Immunomic Therapeutics
Rockville, Maryland, United States
ITI is commercializing a vaccine development platform through the development of product candidates in various stages of clinical testing. It is focused on the treatment on al...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Immunomic Therapeutics

Immunomic Therapeutics
City: Rockville
State: Maryland
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
ITI is commercializing a vaccine development platform through the development of product candidates in various stages of clinical testing. It is focused on the treatment on allergic diseases.

Visit: http://www.immunomix.com
Connect with Immunomic Therapeutics on partnering360®

Biotech Showcase™ 2015
Immunovaccine Inc.
Immunovaccine Inc.
(TSXV:IMV)
Halifax, Nova Scotia, Canada
Immunovaccine Inc. develops cancer immunotherapies and infectious disease vaccines. It has advanced two T cell activation therapies through Phase 1 human trials. It al...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Immunovaccine Inc.

Immunovaccine Inc.
City: Halifax
State: Nova Scotia
Country: Canada
Ownership: PUBLIC
Ticker: IMV
Stock exchange: TSXV
Schedule information will be posted soon
Immunovaccine Inc. develops cancer immunotherapies and infectious disease vaccines. It has advanced two T cell activation therapies through Phase 1 human trials. It also has an infectious disease pipeline that includes a vaccine for respiratory syncytial virus and a collaboration with the NIH for vaccines for Ebola and anthrax.

Visit: http://www.imvaccine.com
Connect with Immunovaccine Inc. on partnering360®

Biotech Showcase™ 2015
Inovio Pharmaceuticals
Inovio Pharmaceuticals
(NASDAQ:INO)
Plymouth Meeting, Pennsylvania, United States
Inovio is a clinical stage company that is developing immunotherapies that activate immune responses to prevent and treat disease that show clinically significant efficacy wit...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Inovio Pharmaceuticals

Inovio Pharmaceuticals
City: Plymouth Meeting
State: Pennsylvania
Country: United States
Ownership: PUBLIC
Ticker: INO
Stock exchange: NASDAQ
Schedule information will be posted soon
Inovio is a clinical stage company that is developing immunotherapies that activate immune responses to prevent and treat disease that show clinically significant efficacy with a favorable safety profile.

Visit: http://www.inovio.com
Connect with Inovio Pharmaceuticals on partnering360®

Biotech Showcase™ 2015
Integene
Integene
Miami, Florida, United States
Integene is a preclinical company developing a platform for gene therapy to treat a broad range of vascular diseases including peripheral arterial disease, critical li...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Integene

Integene
City: Miami
State: Florida
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Integene is a preclinical company developing a platform for gene therapy to treat a broad range of vascular diseases including peripheral arterial disease, critical limb ischemia and coronary artery disease. The company is initially focusing on critical limb ischemia that may qualify for orphan drug designation.

Visit: http://www.integene-int.com
Connect with Integene on partnering360®

Biotech Showcase™ 2015
Intellia
Cambridge, Massachusetts, United States



Share this:Email this pageShare this on LinkedInShare this on Twitter

Intellia

City: Cambridge
State: Massachusetts
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Biotech Showcase™ 2015
Intensity Therapeutics, Inc.
Intensity Therapeutics, Inc.
Westport, Connecticut, United States
This specialty pharmaceutical company develops novel chemotherapeutic products that use advanced imaging, formulation science and immunology in what it calls in situ c...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Intensity Therapeutics, Inc.

Intensity Therapeutics, Inc.
City: Westport
State: Connecticut
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
This specialty pharmaceutical company develops novel chemotherapeutic products that use advanced imaging, formulation science and immunology in what it calls in situ chemovaccination. It is a preclinical, development stage company that has had a Type B pre-NDA meeting with the FDA.

Visit: http://www.intensitytherapeutics.com
Connect with Intensity Therapeutics, Inc. on partnering360®

Biotech Showcase™ 2015
International Stem Cell Corporation
International Stem Cell Corporation
(OTCQB:ISCO)
Carlsbad, California, United States



Share this:Email this pageShare this on LinkedInShare this on Twitter

International Stem Cell Corporation

International Stem Cell Corporation
City: Carlsbad
State: California
Country: United States
Ownership: PUBLIC
Ticker: ISCO
Stock exchange: OTCQB
Schedule information will be posted soon
Biotech Showcase™ 2015
Intezyne
Tampa, Florida, United States
Intezyne is a development stage oncology company. Its lead asset is a small molecule with a new mechanism of action targeting down-regulation of GRP78 a major cancer cell resi...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Intezyne

City: Tampa
State: Florida
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Intezyne is a development stage oncology company. Its lead asset is a small molecule with a new mechanism of action targeting down-regulation of GRP78 a major cancer cell resistance protein. GRP78 is preferentially expressed on the tumor cell surface, enabling specific tumor cell targeting and liming the impact on healthy cells.
Connect with Intezyne on partnering360®

Biotech Showcase™ 2015
Invion Limited
Invion Limited
(ASX:IVX)
Brisbane, Queensland, Australia



Share this:Email this pageShare this on LinkedInShare this on Twitter

Invion Limited

Invion Limited
City: Brisbane
State: Queensland
Country: Australia
Ownership: PUBLIC
Ticker: IVX
Stock exchange: ASX
Schedule information will be posted soon
Biotech Showcase™ 2015
InVivo Therapeutics Corp.
InVivo Therapeutics Corp.
(OTC:NVIV)
Cambridge, Massachusetts, United States



Share this:Email this pageShare this on LinkedInShare this on Twitter

InVivo Therapeutics Corp.

InVivo Therapeutics Corp.
City: Cambridge
State: Massachusetts
Country: United States
Ownership: PUBLIC
Ticker: NVIV
Stock exchange: OTC
Schedule information will be posted soon
Biotech Showcase™ 2015
Isarna Therapeutics
Isarna Therapeutics
Munich, Germany
Isarna develops TGF-ß inhibitors to fight cancer and treat ophthalmic and fibrotic diseases. It is advancing a pipeline of novel oligonucleotides and combination modalities t...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Isarna Therapeutics

Isarna Therapeutics
City: Munich
Country: Germany
Ownership: PUBLIC
Ticker:
Stock exchange:
Schedule information will be posted soon
Isarna develops TGF-ß inhibitors to fight cancer and treat ophthalmic and fibrotic diseases. It is advancing a pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcomes. Its most advanced lead compound will enter the clinic in 2015.

Visit: http://www.isarna-therapeutics.com
Connect with Isarna Therapeutics on partnering360®

Biotech Showcase™ 2015
JDP Therapeutics Inc
JDP Therapeutics Inc
LANSDALE, Pennsylvania, United States
JDP Therapeutics is a clinical Phase 3 stage specialty pharmaceutical company that develops small molecule therapeutics to treat acute allergic reactions, primarily in...


Share this:Email this pageShare this on LinkedInShare this on Twitter

JDP Therapeutics Inc

JDP Therapeutics Inc
City: LANSDALE
State: Pennsylvania
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
JDP Therapeutics is a clinical Phase 3 stage specialty pharmaceutical company that develops small molecule therapeutics to treat acute allergic reactions, primarily in a hospital setting. Its lead product has completed its first Phase 3 clinical study.

Visit: http://www.jdptherapeutics.com/Pages/default.aspx
Connect with JDP Therapeutics Inc on partnering360®

Biotech Showcase™ 2015
Juventas Therapeutics
Juventas Therapeutics
Cleveland, Ohio, United States
Juventas develops biopharmaceuticals that activate the body’s natural regenerative repair processes. Its factor-based therapeutic approach provides an alternative to...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Juventas Therapeutics

Juventas Therapeutics
City: Cleveland
State: Ohio
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Juventas develops biopharmaceuticals that activate the body’s natural regenerative repair processes. Its factor-based therapeutic approach provides an alternative to cellular therapy platforms. The company’s lead product is currently in Phase 2 clinical trials for heart failure and limb ischemia.

Visit: http://www.juventasinc.com
Connect with Juventas Therapeutics on partnering360®

Biotech Showcase™ 2015
Kalos Therapeutics, Inc.
Kalos Therapeutics, Inc.
San. Diego, California, United States
Kalos is a preclinical stage focused on hyperproliferative disorders targeting cancer and age related macular degeneration. It aims to translate the natural hemodynamic contro...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Kalos Therapeutics, Inc.

Kalos Therapeutics, Inc.
City: San. Diego
State: California
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Kalos is a preclinical stage focused on hyperproliferative disorders targeting cancer and age related macular degeneration. It aims to translate the natural hemodynamic controls and antiproliferative activities of the ANO family of peptides into therapies.

Visit: http://www.kalostpx.com
Connect with Kalos Therapeutics, Inc. on partnering360®

Biotech Showcase™ 2015
Karus Therapeutics
Karus Therapeutics
Oxfordshire, United Kingdom
Karus Therapeutics is a preclinical stage company developing medicines for the treatment of inflammatory disease and cancers. It has developed small molecule drugs from its is...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Karus Therapeutics

Karus Therapeutics
City: Oxfordshire
Country: United Kingdom
Ownership: PRIVATE
Schedule information will be posted soon
Karus Therapeutics is a preclinical stage company developing medicines for the treatment of inflammatory disease and cancers. It has developed small molecule drugs from its isoform-selective P13K and HDAC6 inhibitor programs.

Visit: http://www.karustherapeutics.com
Connect with Karus Therapeutics on partnering360®

Biotech Showcase™ 2015
Kesios therapeutics
Kesios therapeutics
London, United Kingdom
Kesios is a preclinical oncology company with a lead compound that should be ready for a Phase 1 proof of concept trial in oncology by the middle of 2015.


Share this:Email this pageShare this on LinkedInShare this on Twitter

Kesios therapeutics

Kesios therapeutics
City: London
Country: United Kingdom
Ownership: PRIVATE
Schedule information will be posted soon
Kesios is a preclinical oncology company with a lead compound that should be ready for a Phase 1 proof of concept trial in oncology by the middle of 2015.

Visit: http://www.kesios.com

Biotech Showcase™ 2015
Kineta, Inc
Kineta, Inc
Seattle, Washington, United States
Kineta develops therapies through the end of Phase 1 and then licenses the drug to pharma on a global or regional basis. It is developing five drug programs with a focus on in...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Kineta, Inc

Kineta, Inc
City: Seattle
State: Washington
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Kineta develops therapies through the end of Phase 1 and then licenses the drug to pharma on a global or regional basis. It is developing five drug programs with a focus on innate immunity and its role in autoimmune (Phase 1) and infectious disease (IND) and non-narcotic chronic pain (pre-IND).

Visit: http://www.kinetabio.com
Connect with Kineta, Inc on partnering360®

Biotech Showcase™ 2015
Kuros Biosurgery AG
Kuros Biosurgery AG
Switzerland, Zürich, Switzerland
Kuros Biosurgery is a clinical stage company developing a dural sealant product and orthobiologics products that are ready for Phase 3 and Phase 2 in trauma and spinal indicat...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Kuros Biosurgery AG

Kuros Biosurgery AG
City: Switzerland
State: Zürich
Country: Switzerland
Ownership: PRIVATE
Schedule information will be posted soon
Kuros Biosurgery is a clinical stage company developing a dural sealant product and orthobiologics products that are ready for Phase 3 and Phase 2 in trauma and spinal indications respectively.

Visit: http://www.kuros.ch
Connect with Kuros Biosurgery AG on partnering360®

Biotech Showcase™ 2015
Lion Biotechnologies
Lion Biotechnologies
(OTC:LBIO)
Woodland Hills, California, United States
This cancer immunotherapy company is developing an adoptive cell therapy with T lymphocytes derived from patients’ tumor or tumor-infiltrating lymphocytes. The company antic...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Lion Biotechnologies

Lion Biotechnologies
City: Woodland Hills
State: California
Country: United States
Ownership: PUBLIC
Ticker: LBIO
Stock exchange: OTC
Schedule information will be posted soon
This cancer immunotherapy company is developing an adoptive cell therapy with T lymphocytes derived from patients’ tumor or tumor-infiltrating lymphocytes. The company anticipates initiating a Phase 2 clinical trial in 2015.

Visit: http://www.lbio.com
Connect with Lion Biotechnologies on partnering360®

Biotech Showcase™ 2015
Luoxis Diagnostics, Inc.
Luoxis Diagnostics, Inc.
Englewood, Colorado, United States
Luoxis is a diagnostic company developing a technology to measure redox potential – also called oxidation-reduction potential or ORP. Redox potential has been implicated in ...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Luoxis Diagnostics, Inc.

Luoxis Diagnostics, Inc.
City: Englewood
State: Colorado
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Luoxis is a diagnostic company developing a technology to measure redox potential – also called oxidation-reduction potential or ORP. Redox potential has been implicated in numerous critical injuries, illnesses and chronic conditions. Its product is approved for marketing in the EU and Canada.

Visit: http://www.luoxis.com
Connect with Luoxis Diagnostics, Inc. on partnering360®

Biotech Showcase™ 2015
Lysosomal Therapeutics
Lysosomal Therapeutics
Cambridge, Massachusetts, United States
Lysosomal Therapeutics is a discovery stage company that leverages lysosomal biology to develop small molecules for the treatment of neurodegenerative disease. It’s ...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Lysosomal Therapeutics

Lysosomal Therapeutics
City: Cambridge
State: Massachusetts
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Lysosomal Therapeutics is a discovery stage company that leverages lysosomal biology to develop small molecules for the treatment of neurodegenerative disease. It’s lead program focuses on Gaucher’s and Parkinson’s disease and is in lead optimization.

Visit: http://www.lysosomaltx.com
Connect with Lysosomal Therapeutics on partnering360®

Biotech Showcase™ 2015
MabVax Therapeutics
MabVax Therapeutics
(OTCQB:MBVX)
San Diego, California, United States
MabVax is a clinical stage biotechnology company that is integrating human antibody discovery technology with multiple therapeutic cancer vaccines. It has two vaccines in late...


Share this:Email this pageShare this on LinkedInShare this on Twitter

MabVax Therapeutics

MabVax Therapeutics
City: San Diego
State: California
Country: United States
Ownership: PUBLIC
Ticker: MBVX
Stock exchange: OTCQB
Schedule information will be posted soon
MabVax is a clinical stage biotechnology company that is integrating human antibody discovery technology with multiple therapeutic cancer vaccines. It has two vaccines in late Phase 2 clinical trials for ovarian cancer and sarcoma. Its lead antibody should enter the clinic by mid-year for pancreatic cancer.

Visit: http://www.mabvax.com
Connect with MabVax Therapeutics on partnering360®

Biotech Showcase™ 2015
Marina Biotech, Inc.
Marina Biotech, Inc.
(OTC:MRNA)
Bothell, Washington, United States



Share this:Email this pageShare this on LinkedInShare this on Twitter

Marina Biotech, Inc.

Marina Biotech, Inc.
City: Bothell
State: Washington
Country: United States
Ownership: PUBLIC
Ticker: MRNA
Stock exchange: OTC
Schedule information will be posted soon
Biotech Showcase™ 2015
Mast Therapeutics, Inc.
Mast Therapeutics, Inc.
(NYSE-M:MSTX)
San Diego, California, United States
Mast Therapeutics is a clinical stage company focused on hematology. Its lead product, currently in a pivotal Phse 3 study, is the most clinically-advanced drug in development...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Mast Therapeutics, Inc.

Mast Therapeutics, Inc.
City: San Diego
State: California
Country: United States
Ownership: PUBLIC
Ticker: MSTX
Stock exchange: NYSE-M
Schedule information will be posted soon
Mast Therapeutics is a clinical stage company focused on hematology. Its lead product, currently in a pivotal Phse 3 study, is the most clinically-advanced drug in development for sickle cell patients. It also has drugs Phase 2 products for acute limb ischemia and acute decompensated heart failure.

Visit: http://www.masttherapeutics.com
Connect with Mast Therapeutics, Inc. on partnering360®

Biotech Showcase™ 2015
Matinas BioPharma
Matinas BioPharma
(OTCQB:MTNB)
Bedminster, New Jersey, United States
Matinas is a development stage biopharmaceutical company identifying and developing drugs to treat blood lipid abnormalities and cardiovascular and metabolic diseases. Its lea...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Matinas BioPharma

Matinas BioPharma
City: Bedminster
State: New Jersey
Country: United States
Ownership: PUBLIC
Ticker: MTNB
Stock exchange: OTCQB
Schedule information will be posted soon
Matinas is a development stage biopharmaceutical company identifying and developing drugs to treat blood lipid abnormalities and cardiovascular and metabolic diseases. Its lead product is designed and formulated for applications in dyslipidemia and the company expects to initiate Phase 3 registration in 2015.

Visit: http://www.matinasbiopharma.com
Connect with Matinas BioPharma on partnering360®

Biotech Showcase™ 2015
MaxCyte, Inc.
MaxCyte, Inc.
Gaithersburg, Maryland, United States



Share this:Email this pageShare this on LinkedInShare this on Twitter

MaxCyte, Inc.

MaxCyte, Inc.
City: Gaithersburg
State: Maryland
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Biotech Showcase™ 2015
Medgenics
Medgenics
(NYSE:MDGN)
Wayne, Pennsylvania, United States
Medgenics is a clinical stage company developing an ex vivo gene therapy platform for the treatment of rare and orphan diseases including renal anemia, beta thalassemi...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Medgenics

Medgenics
City: Wayne
State: Pennsylvania
Country: United States
Ownership: PUBLIC
Ticker: MDGN
Stock exchange: NYSE
Schedule information will be posted soon
Medgenics is a clinical stage company developing an ex vivo gene therapy platform for the treatment of rare and orphan diseases including renal anemia, beta thalassemia, MDS and short bowel syndrome. Its lead product is in Phase 2 clinical trials.

Visit: http://www.medgenics.com/index.php
Connect with Medgenics on partnering360®

Biotech Showcase™ 2015
Medicenna Therapeutics, Inc
Medicenna Therapeutics, Inc
Vancouver, British Columbia, Canada
Medicenna is a clinical stage oncology company with a lead product entering Phase 2b trails for recurrent glioblastoma following compelling efficacy over existing standard of ...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Medicenna Therapeutics, Inc

Medicenna Therapeutics, Inc
City: Vancouver
State: British Columbia
Country: Canada
Ownership: PRIVATE
Schedule information will be posted soon
Medicenna is a clinical stage oncology company with a lead product entering Phase 2b trails for recurrent glioblastoma following compelling efficacy over existing standard of care.

Visit: http://www.medicenna.com
Connect with Medicenna Therapeutics, Inc on partnering360®

Biotech Showcase™ 2015
Medigene AG
Medigene AG
(ETR:MDG1)
Planegg/Martinsried, Germany
Medigene is a commercial stage biotechnology company focused on the development of personalized T cell immunotherapies, particularly those related to haematological malignanci...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Medigene AG

Medigene AG
City: Planegg/Martinsried
Country: Germany
Ownership: PUBLIC
Ticker: MDG1
Stock exchange: ETR
Schedule information will be posted soon
Medigene is a commercial stage biotechnology company focused on the development of personalized T cell immunotherapies, particularly those related to haematological malignancies. It is has one approved drug on the market, Veregen, and several programs in development for the treatment of various cancers.

Visit: http://www.medigene.com
Connect with Medigene AG on partnering360®

Biotech Showcase™ 2015
MedVax Technologies, Inc.
MedVax Technologies, Inc.
Miami Beach, Florida, United States
MedVax is a clinical stage biopharmaceutical company developing cancer vaccines. Its two lead products are focused on antigen presenting cells of the immune system. One has co...


Share this:Email this pageShare this on LinkedInShare this on Twitter

MedVax Technologies, Inc.

MedVax Technologies, Inc.
City: Miami Beach
State: Florida
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
MedVax is a clinical stage biopharmaceutical company developing cancer vaccines. Its two lead products are focused on antigen presenting cells of the immune system. One has completed Phase 2a clinical trials in small cell lung cancer and the other is completing a second Phase 1 study in solid tumors.

Visit: http://www.medvax.net
Connect with MedVax Technologies, Inc. on partnering360®

Biotech Showcase™ 2015
Midatech
Midatech
(AIM:MTPH)
Abingdon, United Kingdom
Midatech is an acquisitive clinical stage specialty pharma company focused on endocrinology, diabetes, neurology and ophthalmology. Its lead product is in Phase 2 clin...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Midatech

Midatech
City: Abingdon
Country: United Kingdom
Ownership: PUBLIC
Ticker: MTPH
Stock exchange: AIM
Schedule information will be posted soon
Midatech is an acquisitive clinical stage specialty pharma company focused on endocrinology, diabetes, neurology and ophthalmology. Its lead product is in Phase 2 clinical trials.
Connect with Midatech on partnering360®

Biotech Showcase™ 2015
Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc.
Montreal, Quebec, Canada
Milestone Pharmaceuticals is a clinical stage company that develops small molecule therapeutics for transient cardiovascular conditions. Its lead product is a treatmen...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc.
City: Montreal
State: Quebec
Country: Canada
Ownership: PRIVATE
Schedule information will be posted soon
Milestone Pharmaceuticals is a clinical stage company that develops small molecule therapeutics for transient cardiovascular conditions. Its lead product is a treatment of paroxysmal supraventricular tachycardia that all allow patients to self-administer at the onset of symptoms. It will begin Phase 2 studies in 2015.

Visit: http://www.milestonepharma.com
Connect with Milestone Pharmaceuticals Inc. on partnering360®

Biotech Showcase™ 2015
MiNA Therapeutics
MiNA Therapeutics
London, United Kingdom
MiNA Therapeutics is a preclinical stage oncology company working on a class of medicines that selectively up-regulate proteins inside patient cells. Its RNA activatio...


Share this:Email this pageShare this on LinkedInShare this on Twitter

MiNA Therapeutics

MiNA Therapeutics
City: London
Country: United Kingdom
Ownership: PRIVATE
Schedule information will be posted soon
MiNA Therapeutics is a preclinical stage oncology company working on a class of medicines that selectively up-regulate proteins inside patient cells. Its RNA activation platform enables up-regulation of beneficial proteins by selective and long lasting transcriptional activation of a target gene.

Visit: http://www.minatx.com
Connect with MiNA Therapeutics on partnering360®

Biotech Showcase™ 2015
Multimeric Biotherapeutics, Inc.
Multimeric Biotherapeutics, Inc.
La Jolla, California, United States
This early clinical stage immune-oncology company is using a ligand based technology platform to develop immune-oncology products and vaccines. Its lead products targe...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Multimeric Biotherapeutics, Inc.

Multimeric Biotherapeutics, Inc.
City: La Jolla
State: California
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
This early clinical stage immune-oncology company is using a ligand based technology platform to develop immune-oncology products and vaccines. Its lead products target ovarian and prostate cancers.

Visit: http://www.multimericbio.com
Connect with Multimeric Biotherapeutics, Inc. on partnering360®

Biotech Showcase™ 2015
NanoViricides, Inc
NanoViricides, Inc
(NYSE:NNVC)
Santa Monica, California, United States
NanoViricides is a preclinical nanobiotech company with a platform technology to rapidly create new targeting anti-virals. Human trials are planned in 2015 for Ebola and Fluci...


Share this:Email this pageShare this on LinkedInShare this on Twitter

NanoViricides, Inc

NanoViricides, Inc
City: Santa Monica
State: California
Country: United States
Ownership: PUBLIC
Ticker: NNVC
Stock exchange: NYSE
Schedule information will be posted soon
NanoViricides is a preclinical nanobiotech company with a platform technology to rapidly create new targeting anti-virals. Human trials are planned in 2015 for Ebola and Flucide (complicated influenza in hospitalized patients).

Visit: http://www.nanoviricides.com
Connect with NanoViricides, Inc on partnering360®

Biotech Showcase™ 2015
Navidea Biopharmaceuticals
Navidea Biopharmaceuticals
(NYSE:NAVB)
Dublin, Ohio, United States
Navidea is a commercial stage company that develops diagnostic and therapeutic radiopharmaceuticals. Its first product has US and European approval and is used to dete...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Navidea Biopharmaceuticals

Navidea Biopharmaceuticals
City: Dublin
State: Ohio
Country: United States
Ownership: PUBLIC
Ticker: NAVB
Stock exchange: NYSE
Schedule information will be posted soon
Navidea is a commercial stage company that develops diagnostic and therapeutic radiopharmaceuticals. Its first product has US and European approval and is used to determine the spread of cancer. The company also plans to apply its core molecule to therapeutics for arthritis, cancer and infectious diseases.

Visit: http://www.navidea.com
Connect with Navidea Biopharmaceuticals on partnering360®

Biotech Showcase™ 2015
NeoStem, Inc.
NeoStem, Inc.
(NASDAQ:NBS)
New York, New York, United States
NeoStem is a clinical stage cellular therapy company pursuing the development of proprietary cell therapy products as well as a revenue-generating contract development...


Share this:Email this pageShare this on LinkedInShare this on Twitter

NeoStem, Inc.

NeoStem, Inc.
City: New York
State: New York
Country: United States
Ownership: PUBLIC
Ticker: NBS
Stock exchange: NASDAQ
Schedule information will be posted soon
NeoStem is a clinical stage cellular therapy company pursuing the development of proprietary cell therapy products as well as a revenue-generating contract development and manufacturing services business. Its lead product is ready for Phase 3 development and it has 2 additional Phase 2 ready programs.

Visit: http://www.neostem.com
Connect with NeoStem, Inc. on partnering360®

Biotech Showcase™ 2015
NetBio
NetBio
Waltham, Massachusetts, United States
NetBio is commercializing products and services in the field of Rapid DNA Analysis. RDNA is performed in the field – at police stations, embassies, borders and ports – by ...


Share this:Email this pageShare this on LinkedInShare this on Twitter

NetBio

NetBio
City: Waltham
State: Massachusetts
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
NetBio is commercializing products and services in the field of Rapid DNA Analysis. RDNA is performed in the field – at police stations, embassies, borders and ports – by non-technical users when timely DNA information is needed. It has raised over $100M in non-dilutive funding to date.

Visit: http://www.netbio.com
Connect with NetBio on partnering360®

Biotech Showcase™ 2015
Neuralstem
Neuralstem
(NYSE-M:CUR)
Germantown, Maryland, United States



Share this:Email this pageShare this on LinkedInShare this on Twitter

Neuralstem

Neuralstem
City: Germantown
State: Maryland
Country: United States
Ownership: PUBLIC
Ticker: CUR
Stock exchange: NYSE-M
Schedule information will be posted soon
Biotech Showcase™ 2015
NeuroMetrix, Inc.
NeuroMetrix, Inc.
(NASDAQ:NURO)
Waltham, Massachusetts, United States
NeuroMetrix develops wearable medical technology and point-of-care tests to help patients and physicians better manage chronic pain, nerve diseases and sleep disorders. It has...


Share this:Email this pageShare this on LinkedInShare this on Twitter

NeuroMetrix, Inc.

NeuroMetrix, Inc.
City: Waltham
State: Massachusetts
Country: United States
Ownership: PUBLIC
Ticker: NURO
Stock exchange: NASDAQ
Schedule information will be posted soon
NeuroMetrix develops wearable medical technology and point-of-care tests to help patients and physicians better manage chronic pain, nerve diseases and sleep disorders. It has FDA cleared prescription and OTC products and focuses on diabetic neuropathies.

Visit: http://www.neurometrix.com
Connect with NeuroMetrix, Inc. on partnering360®

Biotech Showcase™ 2015
Neurotrope, Inc.
Neurotrope, Inc.
(OTCQB:NTRP)
Newark, New Jersey, United States
Neurotrope is developing therapeutics for neurodegenerative diseases such as Alzheimer’s disease and orphan drug indications including Niemann Pick Type C and Fragile X Synd...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Neurotrope, Inc.

Neurotrope, Inc.
City: Newark
State: New Jersey
Country: United States
Ownership: PUBLIC
Ticker: NTRP
Stock exchange: OTCQB
Schedule information will be posted soon
Neurotrope is developing therapeutics for neurodegenerative diseases such as Alzheimer’s disease and orphan drug indications including Niemann Pick Type C and Fragile X Syndrome. The company’s lead compound is currently initiating a Phase 2a clinical trial for the treatment of AD. It is also developing a simple AD diagnostic test.

Visit: http://www.neurotropebioscience.com
Connect with Neurotrope, Inc. on partnering360®

Biotech Showcase™ 2015
Nexstim
Nexstim
helsinki, Finland
Nextim is a medical technology company aimed at improving rehabilitation for stroke patients with noninvasive neurostimulation. It has a marketed diagnostic, an FDA-cleared an...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Nexstim

Nexstim
City: helsinki
Country: Finland
Ownership: PRIVATE
Schedule information will be posted soon
Nextim is a medical technology company aimed at improving rehabilitation for stroke patients with noninvasive neurostimulation. It has a marketed diagnostic, an FDA-cleared and CE-marked navigated Transcranial Magnetic Stimulation device. It also has a therapeutic in Phase 3.

Visit: http://www.nexstim.com
Connect with Nexstim on partnering360®

Biotech Showcase™ 2015
Nordic Nanovector SA
Nordic Nanovector SA
Oslo, Norway
This clinical stage company develops radioimmunotherapeutics for the treatment of severe cancers. Its lead product candidate is currently undergoing a Phase 1/2 clinical trial...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Nordic Nanovector SA

Nordic Nanovector SA
City: Oslo
Country: Norway
Ownership: PRIVATE
Schedule information will be posted soon
This clinical stage company develops radioimmunotherapeutics for the treatment of severe cancers. Its lead product candidate is currently undergoing a Phase 1/2 clinical trial for the treatment of patients with non-Hodgkin Lymphoma.

Visit: http://www.nordicnanovector.com
Connect with Nordic Nanovector SA on partnering360®

Biotech Showcase™ 2015
Northwest Biotherapeutics
Northwest Biotherapeutics
(NASDAQ:NWBO)
Bethesda, Maryland, United States



Share this:Email this pageShare this on LinkedInShare this on Twitter

Northwest Biotherapeutics

Northwest Biotherapeutics
City: Bethesda
State: Maryland
Country: United States
Ownership: PUBLIC
Ticker: NWBO
Stock exchange: NASDAQ
Schedule information will be posted soon
Biotech Showcase™ 2015
Nuvo Research Inc.
Nuvo Research Inc.
(TSX:NRI)
Mississauga, Ontario, Canada
Nuvo Research is a specialty pharmaceutical company with a diverse portfolio of products and technologies. It operates two business units, one devoted to topical products and ...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Nuvo Research Inc.

Nuvo Research Inc.
City: Mississauga
State: Ontario
Country: Canada
Ownership: PUBLIC
Ticker: NRI
Stock exchange: TSX
Schedule information will be posted soon
Nuvo Research is a specialty pharmaceutical company with a diverse portfolio of products and technologies. It operates two business units, one devoted to topical products and technologies and another devoted to immunology. It has four FDA approved products and its lead product for allergic rhinitis is in Phase 2.

Visit: http://www.nuvoresearch.com
Connect with Nuvo Research Inc. on partnering360®

Biotech Showcase™ 2015
Omni Bio Pharmaceutical, Inc.
Omni Bio Pharmaceutical, Inc.
(OTCBB:OMBP)
Fort Collins, Colorado, United States
Omni Bio is an emerging biotech company aiming to revolutionize the way immune-medicated inflammatory diseases are treated. Its target indications include Type 1 diabe...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Omni Bio Pharmaceutical, Inc.

Omni Bio Pharmaceutical, Inc.
City: Fort Collins
State: Colorado
Country: United States
Ownership: PUBLIC
Ticker: OMBP
Stock exchange: OTCBB
Schedule information will be posted soon
Omni Bio is an emerging biotech company aiming to revolutionize the way immune-medicated inflammatory diseases are treated. Its target indications include Type 1 diabetes, graft vs host disease, chronic gout as well as other inflammatory conditions.

Visit: http://www.omnibiopharma.com
Connect with Omni Bio Pharmaceutical, Inc. on partnering360®

Biotech Showcase™ 2015
OncoSec Medical Inc.
OncoSec Medical Inc.
(OTCQB:ONCS)
San Diego, California, United States



Share this:Email this pageShare this on LinkedInShare this on Twitter

OncoSec Medical Inc.

OncoSec Medical Inc.
City: San Diego
State: California
Country: United States
Ownership: PUBLIC
Ticker: ONCS
Stock exchange: OTCQB
Schedule information will be posted soon
Biotech Showcase™ 2015
OncoTab, Inc.
OncoTab, Inc.
Charlotte, North Carolina, United States
OncoTab is a preclinical stage company developing products that span the lifecycle of cancer. Its platform had demonstrated diagnostic and therapeutic potential. It is...


Share this:Email this pageShare this on LinkedInShare this on Twitter

OncoTab, Inc.

OncoTab, Inc.
City: Charlotte
State: North Carolina
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
OncoTab is a preclinical stage company developing products that span the lifecycle of cancer. Its platform had demonstrated diagnostic and therapeutic potential. It is currently conducting prospective clinical studies to detect breast cancer following suspicious mammograms.
Connect with OncoTab, Inc. on partnering360®

Biotech Showcase™ 2015
ONXEO S.A.
ONXEO S.A.
Paris, France
ONXEO is a commercial stage biotech focused on orphan oncology diseases. It has three products in advanced clinical development with potential applications for liver cancer, o...


Share this:Email this pageShare this on LinkedInShare this on Twitter

ONXEO S.A.

ONXEO S.A.
City: Paris
Country: France
Ownership: PRIVATE
Schedule information will be posted soon
ONXEO is a commercial stage biotech focused on orphan oncology diseases. It has three products in advanced clinical development with potential applications for liver cancer, oral mucostis and PTCL. It already has three products approved in either Europe or the US.

Visit: http://www.onxeo.com
Connect with ONXEO S.A. on partnering360®

Biotech Showcase™ 2015
Opsona Therapeutics Ltd
Opsona Therapeutics Ltd
Dublin, Ireland
Opsona Therapeutics is a clinical stage immunology drug development company focused on developing therapeutic approaches to key targets of the innate immune system ass...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Opsona Therapeutics Ltd

Opsona Therapeutics Ltd
City: Dublin
Country: Ireland
Ownership: PRIVATE
Schedule information will be posted soon
Opsona Therapeutics is a clinical stage immunology drug development company focused on developing therapeutic approaches to key targets of the innate immune system associated with a wide range of human disease including autoimmune and inflammatory disease with a specific focus on solid organ transplantation and oncology.

Visit: http://www.opsona.com
Connect with Opsona Therapeutics Ltd on partnering360®

Biotech Showcase™ 2015
ORIG3N
ORIG3N
Boston, Massachusetts, United States
ORIG3N is a preclinical stage biotech company that is developing treatments for rare genetically inherited disease based on cellular reprogramming technology. It curre...


Share this:Email this pageShare this on LinkedInShare this on Twitter

ORIG3N

ORIG3N
City: Boston
State: Massachusetts
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
ORIG3N is a preclinical stage biotech company that is developing treatments for rare genetically inherited disease based on cellular reprogramming technology. It current markets a direct to consumer bio-repository.

Visit: http://www.orig3n.com
Connect with ORIG3N on partnering360®

Biotech Showcase™ 2015
ORYX Translational Medicine
ORYX Translational Medicine
Baldham, Germany
ORYX develops promising cancer projects from research institutions and development through preclinical and clinical phases until proof of concept/efficacy. It oversees...


Share this:Email this pageShare this on LinkedInShare this on Twitter

ORYX Translational Medicine

ORYX Translational Medicine
City: Baldham
Country: Germany
Ownership: PRIVATE
Schedule information will be posted soon
ORYX develops promising cancer projects from research institutions and development through preclinical and clinical phases until proof of concept/efficacy. It oversees a product portfolio of three projects currently in Phase 1/2a clinical trials.

Visit: http://www.oryx-medicine.com
Connect with ORYX Translational Medicine on partnering360®

Biotech Showcase™ 2015
Oxford BioMedica
Oxford BioMedica
(LSE:OXB)
Oxford, United Kingdom
Oxford BioMedica is a clinical stage gene and cell therapy company targeting markets in ophthalmology, CNS and oncology. It has contracts with Novartis covering licens...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Oxford BioMedica

Oxford BioMedica
City: Oxford
Country: United Kingdom
Ownership: PUBLIC
Ticker: OXB
Stock exchange: LSE
Schedule information will be posted soon
Oxford BioMedica is a clinical stage gene and cell therapy company targeting markets in ophthalmology, CNS and oncology. It has contracts with Novartis covering license to its IP and vector manufacture of its lead product.
Connect with Oxford BioMedica on partnering360®

Biotech Showcase™ 2015
Parnell
Parnell
(NASDAQ:PARN)
Overland Park, Kansas, United States
Parnell is a commercial stage animal pharmaceutical company with operations in drug development, manufacturing and commercialization. It has marketed products for catt...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Parnell

Parnell
City: Overland Park
State: Kansas
Country: United States
Ownership: PUBLIC
Ticker: PARN
Stock exchange: NASDAQ
Schedule information will be posted soon
Parnell is a commercial stage animal pharmaceutical company with operations in drug development, manufacturing and commercialization. It has marketed products for cattle fertility and osteoarthritis in dogs and horses. It is developing new products for companion animals in osteoarthritis, dermatology, orthopedics, anesthetics and metabolic diseases.

Visit: http://www.parnell.com
Connect with Parnell on partnering360®

Biotech Showcase™ 2015
Pathoquest
Pathoquest
Paris, France
PathoQuest is a spin-out of the Institut Pasteur that is developing molecular diagnostics in the area of infectious disease that combine Whole Genome NGS and Cloud com...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Pathoquest

Pathoquest
City: Paris
Country: France
Ownership: PRIVATE
Schedule information will be posted soon
PathoQuest is a spin-out of the Institut Pasteur that is developing molecular diagnostics in the area of infectious disease that combine Whole Genome NGS and Cloud computing-based software as a service. It is completing a clinical study and plans a clinical trial in the US in early 2015.

Visit: http://www.pathoquest.com
Connect with Pathoquest on partnering360®

Biotech Showcase™ 2015
PCI Biotech AS
PCI Biotech AS
(OSE Axess:PCIB)
Lysaker, Norway
PCI Biotech is a clinical stage company developing anti-cancer products and a CTL-inducer for therapeutic vaccination using its endosomal escape technology platform. The compa...


Share this:Email this pageShare this on LinkedInShare this on Twitter

PCI Biotech AS

PCI Biotech AS
City: Lysaker
Country: Norway
Ownership: PUBLIC
Ticker: PCIB
Stock exchange: OSE Axess
Schedule information will be posted soon
PCI Biotech is a clinical stage company developing anti-cancer products and a CTL-inducer for therapeutic vaccination using its endosomal escape technology platform. The company target head and neck and bile duct cancers by triggering endosomal escape of established anticancer agents.
Connect with PCI Biotech AS on partnering360®

Biotech Showcase™ 2015
Pediatric Bioscience, Inc.
Pediatric Bioscience, Inc.
San Diego, California, United States
This diagnostic company has developed a novel blood biomarker test for the largest known subtype of autism. The test will allow for earlier diagnosis and treatment of this spe...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Pediatric Bioscience, Inc.

Pediatric Bioscience, Inc.
City: San Diego
State: California
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
This diagnostic company has developed a novel blood biomarker test for the largest known subtype of autism. The test will allow for earlier diagnosis and treatment of this specific form of autism. The company will make the test available in the Fall of 2015 through its CLIA laboratory service model.

Visit: http://www.pedbio.com
Connect with Pediatric Bioscience, Inc. on partnering360®

Biotech Showcase™ 2015
Phylogica Ltd
Phylogica Ltd
(ASX:PYC)
Subiaco. Perth, Western Australia, Australia
Phylogica is a discovery stage company that owns a therapeutic class of peptides. It has entered into five discovery collaborations with large pharmaceutical companies. It has...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Phylogica Ltd

Phylogica Ltd
City: Subiaco. Perth
State: Western Australia
Country: Australia
Ownership: PUBLIC
Ticker: PYC
Stock exchange: ASX
Schedule information will be posted soon
Phylogica is a discovery stage company that owns a therapeutic class of peptides. It has entered into five discovery collaborations with large pharmaceutical companies. It has also recently launched a program to develop drugs against breast cancer.

Visit: http://www.phylogica.com
Connect with Phylogica Ltd on partnering360®

Biotech Showcase™ 2015
PixarBio Corporation
PixarBio Corporation
Medford, Massachusetts, United States
PixarBio, co-founded by Dr. Robert S. Langer of MIT and CEO Frank Reynolds, is a preclinical company that is researching and developing biomaterials to be used in combination ...


Share this:Email this pageShare this on LinkedInShare this on Twitter

PixarBio Corporation

PixarBio Corporation
City: Medford
State: Massachusetts
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
PixarBio, co-founded by Dr. Robert S. Langer of MIT and CEO Frank Reynolds, is a preclinical company that is researching and developing biomaterials to be used in combination with therapeutic agents to treat acute and chronic pain, spinal cord injury, epilepsy and Parkinson’s disease.

Visit: http://www.pixarbio.com
Connect with PixarBio Corporation on partnering360®

Biotech Showcase™ 2015
Polynoma
Polynoma
San Diego, California, United States
Polynoma is a clinical stage immuno-oncology company currently developing a therapeutic vaccine for the treatment of melamoma. It has commences a Phase 3 clinical trial for it...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Polynoma

Polynoma
City: San Diego
State: California
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Polynoma is a clinical stage immuno-oncology company currently developing a therapeutic vaccine for the treatment of melamoma. It has commences a Phase 3 clinical trial for its polyvalent antigen vaccine that contains multiple antigens that are shed from human melanoma cell lines.

Visit: http://www.polynoma.com
Connect with Polynoma on partnering360®

Biotech Showcase™ 2015
Pre Diagnostics AS
Pre Diagnostics AS
Oslo, Norway
This preclinical company is developing a blood-based test for Alzheimer’s disease and pre-dementia. Amyloid plaque formations in AD can be monitored in blood macrophages whe...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Pre Diagnostics AS

Pre Diagnostics AS
City: Oslo
Country: Norway
Ownership: PRIVATE
Schedule information will be posted soon
This preclinical company is developing a blood-based test for Alzheimer’s disease and pre-dementia. Amyloid plaque formations in AD can be monitored in blood macrophages where impeded betaAmyloid-degradation signals disease onset. A new assay was successfully applied identifying pre-dementia clinical samples.

Visit: http://www.pre-diagnostics.com
Connect with Pre Diagnostics AS on partnering360®

Biotech Showcase™ 2015
Prevacus, Inc.
Prevacus, Inc.
Tallahassee, Florida, United States
Prevacus is a preclinical stage drug development company with a lead candidate that is a neurosteroid designed for nasal delivery following acute concussion for up to 14 days....


Share this:Email this pageShare this on LinkedInShare this on Twitter

Prevacus, Inc.

Prevacus, Inc.
City: Tallahassee
State: Florida
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Prevacus is a preclinical stage drug development company with a lead candidate that is a neurosteroid designed for nasal delivery following acute concussion for up to 14 days. It is currently completing IND enabling studies.

Visit: http://www.prevacus.com
Connect with Prevacus, Inc. on partnering360®

Biotech Showcase™ 2015
Prokarium Ltd
Prokarium Ltd
Keele, United Kingdom
Prokarium is a clinical stage vaccine company with a dual diarrhea and typhoid vaccine in Phase I clinical development and clostridium difficile and chlamydia vaccines in pre-...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Prokarium Ltd

Prokarium Ltd
City: Keele
Country: United Kingdom
Ownership: PRIVATE
Schedule information will be posted soon
Prokarium is a clinical stage vaccine company with a dual diarrhea and typhoid vaccine in Phase I clinical development and clostridium difficile and chlamydia vaccines in pre-clinical development. Its oral delivery platform can deliver any protein vaccine orally reducing cost and increasing stability.

Visit: http://www.prokarium.com
Connect with Prokarium Ltd on partnering360®

Biotech Showcase™ 2015
Promentis Pharmaceuticals, Inc.
Promentis Pharmaceuticals, Inc.
Milwaukee, Wisconsin, United States
Promentis is a discovery stage pharmaceutical company that is developing molecules for a variety of central nervous system disorders including schizophrenia, Parkinson...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Promentis Pharmaceuticals, Inc.

Promentis Pharmaceuticals, Inc.
City: Milwaukee
State: Wisconsin
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Promentis is a discovery stage pharmaceutical company that is developing molecules for a variety of central nervous system disorders including schizophrenia, Parkinson’s disease and pediatric disorders including autism.

Visit: http://www.promentispharma.com
Connect with Promentis Pharmaceuticals, Inc. on partnering360®

Biotech Showcase™ 2015
ProMetic Life Sciences Inc.
ProMetic Life Sciences Inc.
(TSX:PLI)
Laval, Quebec, Canada
This clinical stage company specializes in bioseparations, plasma-derived therapeutics and small molecule development. It provides technologies for large-scale purification of...


Share this:Email this pageShare this on LinkedInShare this on Twitter

ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc.
City: Laval
State: Quebec
Country: Canada
Ownership: PUBLIC
Ticker: PLI
Stock exchange: TSX
Schedule information will be posted soon
This clinical stage company specializes in bioseparations, plasma-derived therapeutics and small molecule development. It provides technologies for large-scale purification of biologics, drug development and the elimination of pathogens. It also uses its platform for internal discovery projects.

Visit: http://www.prometic.com
Connect with ProMetic Life Sciences Inc. on partnering360®

Biotech Showcase™ 2015
Protagen
Protagen
Dortmund, Germany
Protagen is a commercial stage diagnostic company that uses a personalized medicine approach to enable differential diagnosis and patient stratification for RA, systemic lupus...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Protagen

Protagen
City: Dortmund
Country: Germany
Ownership: PRIVATE
Schedule information will be posted soon
Protagen is a commercial stage diagnostic company that uses a personalized medicine approach to enable differential diagnosis and patient stratification for RA, systemic lupus erythematosus, MS and other diseases.

Visit: http://www.protagen.com
Connect with Protagen on partnering360®

Biotech Showcase™ 2015
Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc.
Milpitas, California, United States
Protagonist is a preclinical stage company discovering and developing orally stable peptides based on NCEs against validated inflammatory targets and GI diseases. It identifie...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc.
City: Milpitas
State: California
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Protagonist is a preclinical stage company discovering and developing orally stable peptides based on NCEs against validated inflammatory targets and GI diseases. It identified its first development candidate in 2014.

Visit: http://www.protagonist-inc.com
Connect with Protagonist Therapeutics Inc. on partnering360®

Biotech Showcase™ 2015
Protea Biosciences
Protea Biosciences
(OTCBB:PRGB)
Morgantown, West Virginia, United States



Share this:Email this pageShare this on LinkedInShare this on Twitter

Protea Biosciences

Protea Biosciences
City: Morgantown
State: West Virginia
Country: United States
Ownership: PUBLIC
Ticker: PRGB
Stock exchange: OTCBB
Schedule information will be posted soon
Biotech Showcase™ 2015
ProteoTech Inc
ProteoTech Inc
Kirkland, Washington, United States



Share this:Email this pageShare this on LinkedInShare this on Twitter

ProteoTech Inc

ProteoTech Inc
City: Kirkland
State: Washington
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Biotech Showcase™ 2015
Pulmokine
Pulmokine
Rensselaer, New York, United States
Pulmokine is an early-clinical stage company that is developing an inhaled PDGF receptor inhibitor for the treatment of pulmonary arterial hypertension, an orphan disease. The...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Pulmokine

Pulmokine
City: Rensselaer
State: New York
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Pulmokine is an early-clinical stage company that is developing an inhaled PDGF receptor inhibitor for the treatment of pulmonary arterial hypertension, an orphan disease. The company has raised $7 million in non-dilutive funding from the NHLBI to carry its program through a Phase 1 clinical trial.

Visit: http://www.pulmokine.net
Connect with Pulmokine on partnering360®

Biotech Showcase™ 2015
PxRadia Inc.
PxRadia Inc.
Savannah, Georgia, United States



Share this:Email this pageShare this on LinkedInShare this on Twitter

PxRadia Inc.

PxRadia Inc.
City: Savannah
State: Georgia
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Biotech Showcase™ 2015
Q Therapeutics
Q Therapeutics
Salt Lake City, Utah, United States
Q Therapeutics develops neural cell therapeutics to treat diseases of the central nervous system. The company’s first product is a cell-based therapeutic intended to restore...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Q Therapeutics

Q Therapeutics
City: Salt Lake City
State: Utah
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Q Therapeutics develops neural cell therapeutics to treat diseases of the central nervous system. The company’s first product is a cell-based therapeutic intended to restore or preserve normal activity of the neurons in the central nervous system. Its initial clinical target is ALS with its first IND submission expected in early 2015.

Visit: http://www.qthera.com
Connect with Q Therapeutics on partnering360®

Biotech Showcase™ 2015
QBiotics Limited
QBiotics Limited
Indooroopilly, Queensland, Australia
This clinical stage company is developing a clinical-stage NCE for the local treatment of a range of solid tumors in humans and companion animals. It is in Phase 1/2 for human...


Share this:Email this pageShare this on LinkedInShare this on Twitter

QBiotics Limited

QBiotics Limited
City: Indooroopilly
State: Queensland
Country: Australia
Ownership: PRIVATE
Schedule information will be posted soon
This clinical stage company is developing a clinical-stage NCE for the local treatment of a range of solid tumors in humans and companion animals. It is in Phase 1/2 for humans and Phase 2 for animal health. Its pipeline includes a wound-healing product.

Visit: http://www.qbiotics.com
Connect with QBiotics Limited on partnering360®

Biotech Showcase™ 2015
Radius Health, Inc.
Radius Health, Inc.
(NASDAQ:RDUS)
Waltham, Massachusetts, United States
Radius Health is a clinical stage company developing new therapeutics for advanced osteoporosis as well as other serious endocrine-medicated diseases including hormone...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Radius Health, Inc.

Radius Health, Inc.
City: Waltham
State: Massachusetts
Country: United States
Ownership: PUBLIC
Ticker: RDUS
Stock exchange: NASDAQ
Schedule information will be posted soon
Radius Health is a clinical stage company developing new therapeutics for advanced osteoporosis as well as other serious endocrine-medicated diseases including hormone responsive cancers. Its lead candidate is nearly completion of a Phase 3 study to evaluate its ability to reduce fracture risks in postmenopausal women with osteoporosis.

Visit: http://www.radiuspharm.com/
Connect with Radius Health, Inc. on partnering360®

Biotech Showcase™ 2015
Relburn-Metabolomics, Inc.
Relburn-Metabolomics, Inc.
Westfield, New Jersey, United States
This preclinical stage company is developing drugs that treat gout by reducing the production and increasing the excretion of uric acid. This bifunctional activity has...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Relburn-Metabolomics, Inc.

Relburn-Metabolomics, Inc.
City: Westfield
State: New Jersey
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
This preclinical stage company is developing drugs that treat gout by reducing the production and increasing the excretion of uric acid. This bifunctional activity has yielded clinical potency with a drug prototype. It is seeking financing to complete a pre-IND study.

Visit: http://www.relburn.com
Connect with Relburn-Metabolomics, Inc. on partnering360®

Biotech Showcase™ 2015
Reneuron
Reneuron
(LSE:RENE)
Guildford, United Kingdom
ReNeuron is a clinical stage stem cell therapy company. Its primary therapeutic targets are stroke disability, critical limb ischemia and retinitis pigmentosa. Its lea...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Reneuron

Reneuron
City: Guildford
Country: United Kingdom
Ownership: PUBLIC
Ticker: RENE
Stock exchange: LSE
Schedule information will be posted soon
ReNeuron is a clinical stage stem cell therapy company. Its primary therapeutic targets are stroke disability, critical limb ischemia and retinitis pigmentosa. Its lead candidate is in Phase 2 trials, and it is funded to pursue its clinical development program through the next two years.

Visit: http://www.reneuron.com
Connect with Reneuron on partnering360®

Biotech Showcase™ 2015
RepliCel Life Sciences Inc.
RepliCel Life Sciences Inc.
(TSX-V:RP)
Vancouver, British Columbia, Canada
RepliCel is a regenerative medicine company focused on developing autologous cell therapies that treat functional cellular deficits. In the next year it plans to have ...


Share this:Email this pageShare this on LinkedInShare this on Twitter

RepliCel Life Sciences Inc.

RepliCel Life Sciences Inc.
City: Vancouver
State: British Columbia
Country: Canada
Ownership: PUBLIC
Ticker: RP
Stock exchange: TSX-V
Schedule information will be posted soon
RepliCel is a regenerative medicine company focused on developing autologous cell therapies that treat functional cellular deficits. In the next year it plans to have clinical trials underway for chronic Achilles tendinosis, damaged and aging skin, and hair loss.

Visit: http://www.replicel.com
Connect with RepliCel Life Sciences Inc. on partnering360®

Biotech Showcase™ 2015
RestorGenex
RestorGenex
(OTCQB:RESX)
Long Grove, Illinois, United States
RestorGenex is a clinical stage specialty biopharmaceutical company focused on the dermatology, ophthalmology and women’s health markets. Its ophthalmology product t...


Share this:Email this pageShare this on LinkedInShare this on Twitter

RestorGenex

RestorGenex
City: Long Grove
State: Illinois
Country: United States
Ownership: PUBLIC
Ticker: RESX
Stock exchange: OTCQB
Schedule information will be posted soon
RestorGenex is a clinical stage specialty biopharmaceutical company focused on the dermatology, ophthalmology and women’s health markets. Its ophthalmology product targets age-related macular degeneration. Its dermatology business is focused on the treatment of keloid scarring, acne, unwanted excess hair and aging skin.

Visit: http://www.restorgenex.com
Connect with RestorGenex on partnering360®

Biotech Showcase™ 2015
Resverlogix Corp.
Resverlogix Corp.
(TSX:RVX)
Calgary, Alberta, Canada
Resverlogix is developing a small molecule selective BET bromodomain inhibitor for the treatment of patients with cardiovascular disease, diabetes mellitus, Alzheimer...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Resverlogix Corp.

Resverlogix Corp.
City: Calgary
State: Alberta
Country: Canada
Ownership: PUBLIC
Ticker: RVX
Stock exchange: TSX
Schedule information will be posted soon
Resverlogix is developing a small molecule selective BET bromodomain inhibitor for the treatment of patients with cardiovascular disease, diabetes mellitus, Alzheimer’s disease, peripheral artery disease and chronic kidney disease. It has completed Phase 2b trials.

Visit: http://www.resverlogix.com
Connect with Resverlogix Corp. on partnering360®

Biotech Showcase™ 2015
RetroSense Therapeutics
RetroSense Therapeutics
Ann Arbor, Michigan, United States
RetroSense is a preclinical company developing gene therapeutics for vision restoration in retinitis pigmentosa and dry AMD. It anticipates filing an IND in early 2015...


Share this:Email this pageShare this on LinkedInShare this on Twitter

RetroSense Therapeutics

RetroSense Therapeutics
City: Ann Arbor
State: Michigan
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
RetroSense is a preclinical company developing gene therapeutics for vision restoration in retinitis pigmentosa and dry AMD. It anticipates filing an IND in early 2015.

Visit: http://www.retro-sense.com
Connect with RetroSense Therapeutics on partnering360®

Biotech Showcase™ 2015
Rexahn Pharmaceuticals
Rexahn Pharmaceuticals
(NYSE:RNN)
Rockville, Maryland, United States
Rexahn Pharmaceuticals is a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer. The company has three clinical ...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Rexahn Pharmaceuticals

Rexahn Pharmaceuticals
City: Rockville
State: Maryland
Country: United States
Ownership: PUBLIC
Ticker: RNN
Stock exchange: NYSE
Schedule information will be posted soon
Rexahn Pharmaceuticals is a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer. The company has three clinical stage oncology candidates and a pipeline of preclinical compounds to treat multiple types of cancers.

Visit: http://www.rexahn.com
Connect with Rexahn Pharmaceuticals on partnering360®

Biotech Showcase™ 2015
RhinoCyte, Inc.
RhinoCyte, Inc.
Louisville, Kentucky, United States
RhinoCyte is a preclinical stage biotechnology company addressing the treatment of neurodegenerative disease using stem cell technology. It is preparing its lead product for P...


Share this:Email this pageShare this on LinkedInShare this on Twitter

RhinoCyte, Inc.

RhinoCyte, Inc.
City: Louisville
State: Kentucky
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
RhinoCyte is a preclinical stage biotechnology company addressing the treatment of neurodegenerative disease using stem cell technology. It is preparing its lead product for Phase 1/2 trials.

Visit: http://www.rhinocyte.com
Connect with RhinoCyte, Inc. on partnering360®

Biotech Showcase™ 2015
Rock Creek Pharmaceuticals, Inc
Rock Creek Pharmaceuticals, Inc
Sarasota, Florida, United States



Share this:Email this pageShare this on LinkedInShare this on Twitter

Rock Creek Pharmaceuticals, Inc

Rock Creek Pharmaceuticals, Inc
City: Sarasota
State: Florida
Country: United States
Ownership: PUBLIC
Ticker:
Stock exchange:
Schedule information will be posted soon
Biotech Showcase™ 2015
Rogne Bioscience
Rogne Bioscience
Portola Valley, California, United States
Rogne is a preclinical company developing a topical biologic for the treatment of psoriasis. Its lead molecule is a non-steroidal topical with the efficiency of a biol...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Rogne Bioscience

Rogne Bioscience
City: Portola Valley
State: California
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Rogne is a preclinical company developing a topical biologic for the treatment of psoriasis. Its lead molecule is a non-steroidal topical with the efficiency of a biologic which demonstrates potent anti-inflammatory activity.

Visit: http://www.rognebioscience.com
Connect with Rogne Bioscience on partnering360®

Biotech Showcase™ 2015
RXi Pharmaceuticals
RXi Pharmaceuticals
(NASDAQ:RXII)
Marlborough, Massachusetts, United States
RXi Pharmaceuticals is a clinical stage biotechnology company that discovers, develops and commercializes therapies based on its self-delivering RNAi platform. Its fir...


Share this:Email this pageShare this on LinkedInShare this on Twitter

RXi Pharmaceuticals

RXi Pharmaceuticals
City: Marlborough
State: Massachusetts
Country: United States
Ownership: PUBLIC
Ticker: RXII
Stock exchange: NASDAQ
Schedule information will be posted soon
RXi Pharmaceuticals is a clinical stage biotechnology company that discovers, develops and commercializes therapies based on its self-delivering RNAi platform. Its first product candidate is currently being evaluated in Phase 2 clinical trials to reduce the formation of dermal scars.

Visit: http://www.rxipharma.com
Connect with RXi Pharmaceuticals on partnering360®

Biotech Showcase™ 2015
Savara
Savara
Austin, Texas, United States
Savara is a clinical stage specialty pharmaceutical company developing drugs for the treatment of serous and life-threatening conditions. Its lead product in developme...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Savara

Savara
City: Austin
State: Texas
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Savara is a clinical stage specialty pharmaceutical company developing drugs for the treatment of serous and life-threatening conditions. Its lead product in development is a dry power inhaled antibiotic for the treatment of MRSA in patients with cystic fibrosis.

Visit: http://www.savarapharma.com
Connect with Savara on partnering360®

Biotech Showcase™ 2015
Scholar Rock
Scholar Rock
Cambridge, Massachusetts, United States
Scholar Rock is a preclinical stage company discovering biologic therapies that selectively modulate the activation of growth factors in the disease microenvironment. Its curr...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Scholar Rock

Scholar Rock
City: Cambridge
State: Massachusetts
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Scholar Rock is a preclinical stage company discovering biologic therapies that selectively modulate the activation of growth factors in the disease microenvironment. Its current programs target members of the TGF-beta superfamily, which are present in the microenvironments of significant diseases such as fibrosis, diseases of the musculoskeletal system and autoimmune diseases.

Visit: http://www.scholarrock.com
Connect with Scholar Rock on partnering360®

Biotech Showcase™ 2015
Sequenta, Inc.
Sequenta, Inc.
South San Francisco, California, United States
Sequenta uses a platform technology to develop clinical diagnostics to help decode the body’s immune response that has applications across medical conditions and in drug dev...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Sequenta, Inc.

Sequenta, Inc.
City: South San Francisco
State: California
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Sequenta uses a platform technology to develop clinical diagnostics to help decode the body’s immune response that has applications across medical conditions and in drug development. The company’s first commercialized product is a test for MRS in blood cancer patients.

Visit: http://www.sequenta.com
Connect with Sequenta, Inc. on partnering360®

Biotech Showcase™ 2015
SolaranRx, Inc.
SolaranRx, Inc.
Albuquerque, New Mexico, United States
This early-stage company is developing radiopharmaceutical therapies and companion imaging agents to treat metastatic melanoma. It is seeking funding to take its lead product ...


Share this:Email this pageShare this on LinkedInShare this on Twitter

SolaranRx, Inc.

SolaranRx, Inc.
City: Albuquerque
State: New Mexico
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
This early-stage company is developing radiopharmaceutical therapies and companion imaging agents to treat metastatic melanoma. It is seeking funding to take its lead product through proof of concept studies.

Visit: http://www.solaranrx.com
Connect with SolaranRx, Inc. on partnering360®

Biotech Showcase™ 2015
Sorrento Therapeutics, Inc.
Sorrento Therapeutics, Inc.
(NASDAQ:SRNE)
San Diego, California, United States
Sorrento is developing treatments for cancer and associated pain. Its next-generation paclitaxel started its registrational trial in March 2014. It also has a non-opia...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Sorrento Therapeutics, Inc.

Sorrento Therapeutics, Inc.
City: San Diego
State: California
Country: United States
Ownership: PUBLIC
Ticker: SRNE
Stock exchange: NASDAQ
Schedule information will be posted soon
Sorrento is developing treatments for cancer and associated pain. Its next-generation paclitaxel started its registrational trial in March 2014. It also has a non-opiate TRPV1 agonist in a phase 1/2 study at the NIH to treat terminal cancer patients for pain.

Visit: http://www.sorrentotherapeutics.com
Connect with Sorrento Therapeutics, Inc. on partnering360®

Biotech Showcase™ 2015
Stellar Biotechnologies
Stellar Biotechnologies
(OTCQX:SBOTF)
Port Hueneme, California, United States



Share this:Email this pageShare this on LinkedInShare this on Twitter

Stellar Biotechnologies

Stellar Biotechnologies
City: Port Hueneme
State: California
Country: United States
Ownership: PUBLIC
Ticker: SBOTF
Stock exchange: OTCQX
Schedule information will be posted soon
Biotech Showcase™ 2015
StemBioSys, Inc.
StemBioSys, Inc.
San Antonio, Texas, United States



Share this:Email this pageShare this on LinkedInShare this on Twitter

StemBioSys, Inc.

StemBioSys, Inc.
City: San Antonio
State: Texas
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Biotech Showcase™ 2015
Stemedica International
Stemedica International
Lausanne, Switzerland



Share this:Email this pageShare this on LinkedInShare this on Twitter

Stemedica International

Stemedica International
City: Lausanne
Country: Switzerland
Ownership: PRIVATE
Schedule information will be posted soon
Biotech Showcase™ 2015
Synthetic Biologics, Inc.
Synthetic Biologics, Inc.
(NYSE-M:SYN)
Rockville, Maryland, United States
Synthetic Biologics is clinical stage company developing pathogen-specific therapies with a focus on the microbiome to protect the GI microflora from the effects of IV antibio...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Synthetic Biologics, Inc.

Synthetic Biologics, Inc.
City: Rockville
State: Maryland
Country: United States
Ownership: PUBLIC
Ticker: SYN
Stock exchange: NYSE-M
Schedule information will be posted soon
Synthetic Biologics is clinical stage company developing pathogen-specific therapies with a focus on the microbiome to protect the GI microflora from the effects of IV antibiotics in order to prevent C. diffilcile infection, reduct the impact of methane producing organisms on C-IBS, treat pertussis and treat relapsing-remitting MS.

Visit: http://www.syntheticbiologics.com
Connect with Synthetic Biologics, Inc. on partnering360®

Biotech Showcase™ 2015
TesoRx
TesoRx
Menlo Park, California, United States



Share this:Email this pageShare this on LinkedInShare this on Twitter

TesoRx

TesoRx
City: Menlo Park
State: California
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Biotech Showcase™ 2015
Theranostics Health, Inc.
Theranostics Health, Inc.
Rockville, Maryland, United States
This revenue-generating company is a provider of proteomic-based molecular diagnostic assays for oncologists that measure signaling activity across a panel of drug targets in ...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Theranostics Health, Inc.

Theranostics Health, Inc.
City: Rockville
State: Maryland
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
This revenue-generating company is a provider of proteomic-based molecular diagnostic assays for oncologists that measure signaling activity across a panel of drug targets in each unique tumor. Its marketed product is used in breast cancer, and it plans to expand into colorectal and lung cancers in 2015.

Visit: http://www.theranosticshealth.com
Connect with Theranostics Health, Inc. on partnering360®

Biotech Showcase™ 2015
Therapix Biosciences
Therapix Biosciences
(TASE:TRPX)
Tel Aviv, Israel
Therapix is a preclinical specialty pharmaceutical company that is focusing on the microbiome to protect the GI microflora from the effects of IV antibiotics to prevent or tre...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Therapix Biosciences

Therapix Biosciences
City: Tel Aviv
Country: Israel
Ownership: PUBLIC
Ticker: TRPX
Stock exchange: TASE
Schedule information will be posted soon
Therapix is a preclinical specialty pharmaceutical company that is focusing on the microbiome to protect the GI microflora from the effects of IV antibiotics to prevent or treat infectious diseases such as C. difficile infection as well as diseases of the central nervous system including MS.

Visit: http://www.therapixbio.com/
Connect with Therapix Biosciences on partnering360®

Biotech Showcase™ 2015
Thermalin Diabetes, LLC
Thermalin Diabetes, LLC
Waban, Massachusetts, United States
Thermalin is a preclinical stage diabetes company with new delivery technologies including never-needs-refrigeration insulins and rapid acting insulins. It lead product is ent...


Share this:Email this pageShare this on LinkedInShare this on Twitter

Thermalin Diabetes, LLC

Thermalin Diabetes, LLC
City: Waban
State: Massachusetts
Country: United States
Ownership: PRIVATE
Schedule information will be posted soon
Thermalin is a preclinical stage diabetes company with new delivery technologies including never-needs-refrigeration insulins and rapid acting insulins. It lead product is entering Phase 1 trials.

Visit: http://www.thermalin.com
Connect with Thermalin Diabetes, LLC on partnering360®

Biotech Showcase™ 2015
TIGENIX NV
TIGENIX NV
(EURONEXT:TIG)
LEUVEN, Belgium
This revenue-generating company is a provider of proteomic-based molecular diagnostic assays for oncologists that measure signaling activity across a panel of drug targets in ...


Share this:Email this pageShare this on LinkedInShare this on Twitter

TIGENIX NV

TIGENIX NV
City: LEUVEN
Country: Belgium
Ownership: PUBLIC
Ticker: TIG
Stock exchange: EURONEXT
Schedule information will be posted soon
This revenue-generating company is a provider of proteomic-based molecular diagnostic assays for oncologists that measure signaling activity across a panel of drug targets in each unique tumor. Its marketed product is used in breast cancer, and it plans to expand into colorectal and lung cancers in 2015.

Visit: http://www.tigenix.com
Connect with TIGENIX NV on partnering360®

Biotech Showcase™ 2015
Tolero Pharmaceuticals, Inc.
Tolero Pharmaceuticals, Inc.
Lehi, Utah, United States
Tolero develops therapeutics for life-threatening diseases. Its pipeline includes one product for myeloid leukemia in Phase 2 and several others in preclinical development inc...


Share this: